#Pdb,Mutation(s)_PDB,Mutation(s)_cleaned,iMutation_Location(s),Hold_out_type,Hold_out_proteins,Affinity_mut (M),Affinity_mut_parsed,Affinity_wt (M),Affinity_wt_parsed,Reference,Protein 1,Protein 2,Temperature,kon_mut (M^(-1)s^(-1)),kon_mut_parsed,kon_wt (M^(-1)s^(-1)),kon_wt_parsed,koff_mut (s^(-1)),koff_mut_parsed,koff_wt (s^(-1)),koff_wt_parsed,dH_mut (kcal mol^(-1)),dH_wt (kcal mol^(-1)),dS_mut (cal mol^(-1) K^(-1)),dS_wt (cal mol^(-1) K^(-1)),Notes,Method,SKEMPI version,dG_wt,dG_mut,score,pdbid,PDB_filename_pyrosetta_mutant,chainid,variant
1CSE_E_I,LI45G,LI38G,COR,Pr/PI,Pr/PI,5.26E-11,5.26e-11,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-14.0223342469332,2.280577221745121,1CSE,1CSE_LI38G,I,L38G
1CSE_E_I,LI45S,LI38S,COR,Pr/PI,Pr/PI,8.33E-12,8.33e-12,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-15.1141359632168,1.1887755054615212,1CSE,1CSE_LI38S,I,L38S
1CSE_E_I,LI45P,LI38P,COR,Pr/PI,Pr/PI,1.02E-07,1.02e-07,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-9.537465636818943,6.7654458318593775,1CSE,1CSE_LI38P,I,L38P
1CSE_E_I,LI45I,LI38I,COR,Pr/PI,Pr/PI,1.72E-10,1.72e-10,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-13.32040995898597,2.9825015096923515,1CSE,1CSE_LI38I,I,L38I
1CSE_E_I,LI45D,LI38D,COR,Pr/PI,Pr/PI,1.92E-09,1.92e-09,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-11.891068604310233,4.41184286436809,1CSE,1CSE_LI38D,I,L38D
1CSE_E_I,LI45E,LI38E,COR,Pr/PI,Pr/PI,6.25E-11,6.25e-11,1.12E-12,1.12e-12,9048543,Subtilisin Carlsberg,Eglin c,294,,,,,,,,,,,,,,IASP,1,-16.30291146867832,-13.920165643435183,2.3827458252431377,1CSE,1CSE_LI38E,I,L38E
1Y48_E_I,AI65R,AI46R,INT,Pr/PI,Pr/PI,3E-12,3e-12,1.7E-09,1.7e-09,15865427,Subtilisin BPN,Chymotrypsin inhibitor 2,298,,,,,,,,,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",IASP,1,-11.963168194853663,-15.71917824331304,-3.756010048459375,1Y48,1Y48_AI46R,I,A46R
1TM5_E_I,AI59M,AI40M,COR,Pr/PI,Pr/PI,3E-12,3e-12,1.7E-11,1.7e-11,15504027,Subtilisin BPN,Chymotrypsin inhibitor 2,298(assumed),,,,,,,,,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",IASP,1,-14.69151040703766,-15.71917824331304,-1.0276678362753788,1TM5,1TM5_AI40M,I,A40M
1TMG_E_I,FI59M,FI40M,COR,Pr/PI,Pr/PI,3E-12,3e-12,1.7E-11,1.7e-11,15504027,Subtilisin BPN,Chymotrypsin inhibitor 2,298(assumed),,,,,,,,,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",IASP,1,-14.69151040703766,-15.71917824331304,-1.0276678362753788,1TMG,1TMG_FI40M,I,F40M
1TO1_E_I,AI61Y,AI42Y,COR,Pr/PI,Pr/PI,3E-12,3e-12,4.6E-10,4.6e-10,15504027,Subtilisin BPN,Chymotrypsin inhibitor 2,298(assumed),,,,,,,,,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",IASP,1,-12.737595976603783,-15.71917824331304,-2.981582266709255,1TO1,1TO1_AI42Y,I,A42Y
2JEL_LH_P,FP2Y,FP2Y,COR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_FP2Y,P,F2Y
2JEL_LH_P,FP2W,FP2W,COR,AB/AG,AB/AG,2.5E-07,2.5e-07,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-9.006339480855587,2.6203254441814625,2JEL,2JEL_FP2W,P,F2W
2JEL_LH_P,QP3K,QP3K,COR,AB/AG,AB/AG,3E-06,3e-06,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-7.53415160676106,4.09251331827599,2JEL,2JEL_QP3K,P,Q3K
2JEL_LH_P,QP4K,QP4K,COR,AB/AG,AB/AG,3E-08,3e-08,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-10.262493818945051,1.3641711060919963,2JEL,2JEL_QP4K,P,Q4K
2JEL_LH_P,EP5D,EP5D,RIM,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_EP5D,P,E5D
2JEL_LH_P,EP5Q,EP5Q,RIM,AB/AG,AB/AG,1E-08,1e-08,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-10.913368848735976,0.7132960763010736,2JEL,2JEL_EP5Q,P,E5Q
2JEL_LH_P,VP6F,VP6F,INT,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_VP6F,P,V6F
2JEL_LH_P,TP7N,TP7N,SUR,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_TP7N,P,T7N
2JEL_LH_P,TP7S,TP7S,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_TP7S,P,T7S
2JEL_LH_P,PP11E,PP11E,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_PP11E,P,P11E
2JEL_LH_P,NP12D,NP12D,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_NP12D,P,N12D
2JEL_LH_P,RP17G,RP17G,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_RP17G,P,R17G
2JEL_LH_P,RP17K,RP17K,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_RP17K,P,R17K
2JEL_LH_P,KP24E,KP24E,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_KP24E,P,K24E
2JEL_LH_P,KP27E,KP27E,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_KP27E,P,K27E
2JEL_LH_P,TP34N,TP34N,COR,AB/AG,AB/AG,>3E-04,0.0003,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,2,-11.62666492503705,-4.805809394577065,6.820855530459984,2JEL,2JEL_TP34N,P,T34N
2JEL_LH_P,TP34Q,TP34Q,COR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_TP34Q,P,T34Q
2JEL_LH_P,TP36Q,TP36Q,COR,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_TP36Q,P,T36Q
2JEL_LH_P,NP38T,NP38T,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_NP38T,P,N38T
2JEL_LH_P,SP41C,SP41C,RIM,AB/AG,AB/AG,3.75E-08,3.75e-08,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-10.130291979308462,1.496372945728588,2JEL,2JEL_SP41C,P,S41C
2JEL_LH_P,SP43C,SP43C,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_SP43C,P,S43C
2JEL_LH_P,SP46C,SP46C,INT,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_SP46C,P,S46C
2JEL_LH_P,QP57E,QP57E,SUR,AB/AG,AB/AG,1.5E-09,1.5e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-12.037321347188852,-0.4106564221518027,2JEL,2JEL_QP57E,P,Q57E
2JEL_LH_P,TP62N,TP62N,INT,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_TP62N,P,T62N
2JEL_LH_P,TP62A,TP62A,INT,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_TP62A,P,T62A
2JEL_LH_P,SP64T,SP64T,SUP,AB/AG,AB/AG,3E-06,3e-06,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-7.53415160676106,4.09251331827599,2JEL,2JEL_SP64T,P,S64T
2JEL_LH_P,EP66K,EP66K,COR,AB/AG,AB/AG,>3E-06,3e-06,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-7.53415160676106,4.09251331827599,2JEL,2JEL_EP66K,P,E66K
2JEL_LH_P,EP68A,EP68A,RIM,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_EP68A,P,E68A
2JEL_LH_P,DP69E,DP69E,INT,AB/AG,AB/AG,1.5E-08,1.5e-08,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-10.673150241096856,0.9535146839401936,2JEL,2JEL_DP69E,P,D69E
2JEL_LH_P,EP70K,EP70K,SUP,AB/AG,AB/AG,>3E-06,3e-06,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-7.53415160676106,4.09251331827599,2JEL,2JEL_EP70K,P,E70K
2JEL_LH_P,EP70A,EP70A,SUP,AB/AG,AB/AG,>3E-07,3e-07,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-8.898322712853057,2.7283422121839926,2JEL,2JEL_EP70A,P,E70A
2JEL_LH_P,QP71E,QP71E,COR,AB/AG,AB/AG,3E-07,3e-07,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-8.898322712853057,2.7283422121839926,2JEL,2JEL_QP71E,P,Q71E
2JEL_LH_P,KP72R,KP72R,RIM,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_KP72R,P,K72R
2JEL_LH_P,KP72E,KP72E,RIM,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_KP72E,P,K72E
2JEL_LH_P,EP75R,EP75R,COR,AB/AG,AB/AG,3E-07,3e-07,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-8.898322712853057,2.7283422121839926,2JEL,2JEL_EP75R,P,E75R
2JEL_LH_P,HP76D,HP76D,RIM,AB/AG,AB/AG,1E-09,1e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-12.277539954827974,-0.6508750297909245,2JEL,2JEL_HP76D,P,H76D
2JEL_LH_P,HP76A,HP76A,RIM,AB/AG,AB/AG,1.5E-09,1.5e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-12.037321347188852,-0.4106564221518027,2JEL,2JEL_HP76A,P,H76A
2JEL_LH_P,KP79E,KP79E,RIM,AB/AG,AB/AG,6E-09,6e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.216008502885249,0.410656422151801,2JEL,2JEL_KP79E,P,K79E
2JEL_LH_P,AP82S,AP82S,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_AP82S,P,A82S
2JEL_LH_P,EP83A,EP83A,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_EP83A,P,E83A
2JEL_LH_P,EP85Q,EP85Q,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_EP85Q,P,E85Q
2JEL_LH_P,EP85D,EP85D,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_EP85D,P,E85D
2JEL_LH_P,EP85A,EP85A,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_EP85A,P,E85A
2JEL_LH_P,EP85K,EP85K,SUR,AB/AG,AB/AG,3E-09,3e-09,3E-09,3e-09,1711212,Antibody Jel42,Histadine-containing protein HPr,298(assumed),,,,,,,,,,,,,"Unusual method,,",CSPRIA,1,-11.62666492503705,-11.62666492503705,0.0,2JEL,2JEL_EP85K,P,E85K
1REW_AB_C,QC86A,QC55A,COR,,"1REW_AB_C,2QJ9_AB_C,2QJA_AB_C,2QJB_AB_C,1KTZ_A_B",8E-08,8e-08,9E-10,9e-10,15064755,Bone morphogenetic protein-2,BMPR-IA receptor,298(assumed),,,,,,,,,,,,,,SPR,1,-12.339961001338123,-9.68139958228057,2.6585614190575537,1REW,1REW_QC55A,C,Q55A
1FFW_A_B,DA13K,DA12K,SUR,,1FFW_A_B,1.3E-06,1.3e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-8.029588407603734,0.047421460945717,1FFW,1FFW_DA12K,A,D12K
1FFW_A_B,TA87I,TA86I,INT,,1FFW_A_B,7E-07,7e-07,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-8.396339414641552,-0.319329546092101,1FFW,1FFW_TA86I,A,T86I
1FFW_A_B,AA90V,AA89V,RIM,,1FFW_A_B,1.4E-06,1.4e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-7.9856829924897506,0.0913268760597008,1FFW,1FFW_AA89V,A,A89V
1FFW_A_B,EA93K,EA92K,SUR,,1FFW_A_B,4.8E-06,4.8e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-7.255697024245847,0.8213128443036046,1FFW,1FFW_EA92K,A,E92K
1FFW_A_B,YA106W,YA105W,COR,,1FFW_A_B,4E-06,4e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-7.363713792248378,0.7132960763010736,1FFW,1FFW_YA105W,A,Y105W
1FFW_A_B,VA108M,VA107M,SUR,,1FFW_A_B,8.1E-06,8.1e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-6.945697623480286,1.1313122450691653,1FFW,1FFW_VA107M,A,V107M
1FFW_A_B,FA111V,FA110V,INT,,1FFW_A_B,1E-05,1e-05,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-6.820855530459986,1.2561543380894653,1FFW,1FFW_FA110V,A,F110V
1FFW_A_B,TA112I,TA111I,SUR,,1FFW_A_B,3.1E-06,3.1e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-7.514725211182846,0.5622846573666056,1FFW,1FFW_TA111I,A,T111I
1FFW_A_B,EA117K,EA116K,SUR,,1FFW_A_B,4E-06,4e-06,1.2E-06,1.2e-06,7592655,Chemotaxis protein CheY,Chemotaxis protein CheA,298(assumed),,,,,,,,,,,,,,ELISA,1,-8.077009868549451,-7.363713792248378,0.7132960763010736,1FFW,1FFW_EA116K,A,E116K
1FFW_A_B,EB171A,EB13A,SUP,,1FFW_A_B,5.7E-07,5.7e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-8.518055104714108,0.7167708779555646,1FFW,1FFW_EB13A,B,E13A
1FFW_A_B,EB178A,EB20A,COR,,1FFW_A_B,5E-07,5e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-8.595683058703784,0.6391429239658883,1FFW,1FFW_EB20A,B,E20A
1FFW_A_B,HB181A,HB23A,RIM,,1FFW_A_B,1.8E-07,1.8e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-9.200962367002328,0.0338636156673448,1FFW,1FFW_HB23A,B,H23A
1FFW_A_B,DB202A,DB44A,RIM,,1FFW_A_B,1.5E-07,1.5e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-9.308979135004858,-0.0741531523351852,1FFW,1FFW_DB44A,B,D44A
1FFW_A_B,DB207A,DB49A,RIM,,1FFW_A_B,2E-07,2e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-9.138541320492177,0.0962846621774957,1FFW,1FFW_DB49A,B,D49A
1FFW_A_B,CB213A,CB55A,RIM,,1FFW_A_B,2.4E-07,2.4e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-9.030524552489648,0.2043014301800259,1FFW,1FFW_CB55A,B,C55A
1FFW_A_B,FB214A,FB56A,COR,,1FFW_A_B,8E-05,8e-05,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-5.588886264004579,3.645939718665094,1FFW,1FFW_FB56A,B,F56A
1FFW_A_B,IB216A,IB58A,SUP,,1FFW_A_B,3.5E-07,3.5e-07,1.7E-07,1.7e-07,21642453,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,,,,,,FL,1,-9.234825982669673,-8.806995836793353,0.4278301458763192,1FFW,1FFW_IB58A,B,I58A
1R0R_E_I,LI18G,LI13G,COR,Pr/PI,Pr/PI,1.56E-09,1.56e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.014084957877197,2.3528913133711846,1R0R,1R0R_LI13G,I,L13G
1R0R_E_I,LI18A,LI13A,COR,Pr/PI,Pr/PI,5E-11,5e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.052367483071771,0.3146087881766082,1R0R,1R0R_LI13A,I,L13A
1R0R_E_I,LI18S,LI13S,COR,Pr/PI,Pr/PI,4.17E-10,4.17e-10,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.795739372878892,1.571236898369488,1R0R,1R0R_LI13S,I,L13S
1R0R_E_I,LI18C,LI13C,COR,Pr/PI,Pr/PI,3.03E-12,3.03e-12,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.713283150060136,-1.346306878811756,1R0R,1R0R_LI13C,I,L13C
1R0R_E_I,LI18V,LI13V,COR,Pr/PI,Pr/PI,1.12E-09,1.12e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.21039815040233,2.156578120846051,1R0R,1R0R_LI13V,I,L13V
1R0R_E_I,LI18T,LI13T,COR,Pr/PI,Pr/PI,3.85E-11,3.85e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.20721355606493,0.1597627151834508,1R0R,1R0R_LI13T,I,L13T
1R0R_E_I,LI18P,LI13P,COR,Pr/PI,Pr/PI,1.27E-05,1.27e-05,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-6.679249493627032,7.687726777621349,1R0R,1R0R_LI13P,I,L13P
1R0R_E_I,LI18I,LI13I,COR,Pr/PI,Pr/PI,7.14E-09,7.14e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.11294952100051,3.2540267502478706,1R0R,1R0R_LI13I,I,L13I
1R0R_E_I,LI18M,LI13M,COR,Pr/PI,Pr/PI,1.23E-11,1.23e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.88323621169636,-0.5162599404479788,1R0R,1R0R_LI13M,I,L13M
1R0R_E_I,LI18N,LI13N,COR,Pr/PI,Pr/PI,3.7E-10,3.7e-10,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.866586686516118,1.5003895847322628,1R0R,1R0R_LI13N,I,L13N
1R0R_E_I,LI18D,LI13D,COR,Pr/PI,Pr/PI,6.25E-08,6.25e-08,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.827652325159193,4.539323946089189,1R0R,1R0R_LI13D,I,L13D
1R0R_E_I,LI18K,LI13K,COR,Pr/PI,Pr/PI,8.33E-09,8.33e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.021622644940807,3.345353626307574,1R0R,1R0R_LI13K,I,L13K
1R0R_E_I,LI18Q,LI13Q,COR,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_LI13Q,I,L13Q
1R0R_E_I,LI18E,LI13E,COR,Pr/PI,Pr/PI,1.16E-09,1.16e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.189608228367824,2.1773680428805573,1R0R,1R0R_LI13E,I,L13E
1R0R_E_I,LI18H,LI13H,COR,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_LI13H,I,L13H
1R0R_E_I,LI18F,LI13F,COR,Pr/PI,Pr/PI,8.33E-11,8.33e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.749964857124803,0.6170114141235779,1R0R,1R0R_LI13F,I,L13F
1R0R_E_I,LI18R,LI13R,COR,Pr/PI,Pr/PI,4.17E-09,4.17e-09,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.431568266786895,2.935408004461486,1R0R,1R0R_LI13R,I,L13R
1R0R_E_I,LI18Y,LI13Y,COR,Pr/PI,Pr/PI,6.25E-11,6.25e-11,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.920165643435183,0.446810627813198,1R0R,1R0R_LI13Y,I,L13Y
1R0R_E_I,LI18W,LI13W,COR,Pr/PI,Pr/PI,3.85E-10,3.85e-10,2.94E-11,2.94e-11,9047374,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.843042449972932,1.523933821275449,1R0R,1R0R_LI13W,I,L13W
1R0R_E_I,AI15G,AI10G,COR,Pr/PI,Pr/PI,1.92E-10,1.92e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.255239710402227,1.1117365608461522,1R0R,1R0R_AI10G,I,A10G
1R0R_E_I,AI15S,AI10S,COR,Pr/PI,Pr/PI,5.56E-10,5.56e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.625301558366212,1.741674712882169,1R0R,1R0R_AI10S,I,A10S
1R0R_E_I,AI15C,AI10C,COR,Pr/PI,Pr/PI,1.3E-11,1.3e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.85044393806372,-0.4834676668153399,1R0R,1R0R_AI10C,I,A10C
1R0R_E_I,AI15V,AI10V,COR,Pr/PI,Pr/PI,5.88E-12,5.88e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.320490955188577,-0.9535146839401952,1R0R,1R0R_AI10V,I,A10V
1R0R_E_I,AI15T,AI10T,COR,Pr/PI,Pr/PI,2.5E-10,2.5e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.098852799131578,1.2681234721168035,1R0R,1R0R_AI10T,I,A10T
1R0R_E_I,AI15P,AI10P,COR,Pr/PI,Pr/PI,8.33E-09,8.33e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.021622644940807,3.345353626307574,1R0R,1R0R_AI10P,I,A10P
1R0R_E_I,AI15L,AI10L,COR,Pr/PI,Pr/PI,1.52E-12,1.52e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.121987504601606,-1.7550112333532244,1R0R,1R0R_AI10L,I,A10L
1R0R_E_I,AI15I,AI10I,COR,Pr/PI,Pr/PI,1.41E-12,1.41e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.166492871142808,-1.7995165998944262,1R0R,1R0R_AI10I,I,A10I
1R0R_E_I,AI15M,AI10M,COR,Pr/PI,Pr/PI,1.56E-12,1.56e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.106598276153186,-1.7396220049048043,1R0R,1R0R_AI10M,I,A10M
1R0R_E_I,AI15N,AI10N,COR,Pr/PI,Pr/PI,1E-09,1e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.277539954827974,2.0894363164204077,1R0R,1R0R_AI10N,I,A10N
1R0R_E_I,AI15D,AI10D,COR,Pr/PI,Pr/PI,2E-07,2e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.138541320492177,5.2284349507562045,1R0R,1R0R_AI10D,I,A10D
1R0R_E_I,AI15K,AI10K,COR,Pr/PI,Pr/PI,5.26E-09,5.26e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.293992034749207,3.072984236499174,1R0R,1R0R_AI10K,I,A10K
1R0R_E_I,AI15Q,AI10Q,COR,Pr/PI,Pr/PI,6.25E-10,6.25e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.555994537343183,1.810981733905196,1R0R,1R0R_AI10Q,I,A10Q
1R0R_E_I,AI15E,AI10E,COR,Pr/PI,Pr/PI,6.67E-08,6.67e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.78912019832305,4.577856072925332,1R0R,1R0R_AI10E,I,A10E
1R0R_E_I,AI15H,AI10H,COR,Pr/PI,Pr/PI,5.88E-10,5.88e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.592148743004582,1.774827528243799,1R0R,1R0R_AI10H,I,A10H
1R0R_E_I,AI15F,AI10F,COR,Pr/PI,Pr/PI,6.67E-13,6.67e-13,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.609975728783034,-2.242999457534653,1R0R,1R0R_AI10F,I,A10F
1R0R_E_I,AI15R,AI10R,COR,Pr/PI,Pr/PI,3.33E-07,3.33e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.836494414750277,5.530481856498104,1R0R,1R0R_AI10R,I,A10R
1R0R_E_I,AI15Y,AI10Y,COR,Pr/PI,Pr/PI,7.14E-12,7.14e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.2054628392765,-0.8384865680281202,1R0R,1R0R_AI10Y,I,A10Y
1R0R_E_I,AI15W,AI10W,COR,Pr/PI,Pr/PI,4.17E-11,4.17e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P4. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.159910478970888,0.2070657922774934,1R0R,1R0R_AI10W,I,A10W
1R0R_E_I,TI17G,TI12G,COR,Pr/PI,Pr/PI,5.88E-09,5.88e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.227977636912586,3.1389986343357954,1R0R,1R0R_TI12G,I,T12G
1R0R_E_I,TI17A,TI12A,COR,Pr/PI,Pr/PI,2.13E-10,2.13e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.193745094078896,1.1732311771694857,1R0R,1R0R_TI12A,I,T12A
1R0R_E_I,TI17S,TI12S,COR,Pr/PI,Pr/PI,1.32E-10,1.32e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.477227587821028,0.8897486834273547,1R0R,1R0R_TI12S,I,T12S
1R0R_E_I,TI17C,TI12C,COR,Pr/PI,Pr/PI,1.16E-10,1.16e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.55377933445982,0.8131969367885628,1R0R,1R0R_TI12C,I,T12C
1R0R_E_I,TI17V,TI12V,COR,Pr/PI,Pr/PI,1.43E-10,1.43e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.42980612687531,0.9371701443730718,1R0R,1R0R_TI12V,I,T12V
1R0R_E_I,TI17P,TI12P,COR,Pr/PI,Pr/PI,1.25E-07,1.25e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.41699590300739,4.949980368240992,1R0R,1R0R_TI12P,I,T12P
1R0R_E_I,TI17L,TI12L,COR,Pr/PI,Pr/PI,9.09E-11,9.09e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.698237014177217,0.6687392570711648,1R0R,1R0R_TI12L,I,T12L
1R0R_E_I,TI17I,TI12I,COR,Pr/PI,Pr/PI,4.55E-11,4.55e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.108242032213097,0.2587342390352862,1R0R,1R0R_TI12I,I,T12I
1R0R_E_I,TI17M,TI12M,COR,Pr/PI,Pr/PI,2.78E-10,2.78e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.035957980518011,1.331018290730368,1R0R,1R0R_TI12M,I,T12M
1R0R_E_I,TI17N,TI12N,COR,Pr/PI,Pr/PI,3.03E-11,3.03e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.34911204396814,0.0178642272802402,1R0R,1R0R_TI12N,I,T12N
1R0R_E_I,TI17D,TI12D,COR,Pr/PI,Pr/PI,3.85E-09,3.85e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.478871343880934,2.888104927367447,1R0R,1R0R_TI12D,I,T12D
1R0R_E_I,TI17K,TI12K,COR,Pr/PI,Pr/PI,7.69E-10,7.69e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.433155946037015,1.9338203252113644,1R0R,1R0R_TI12K,I,T12K
1R0R_E_I,TI17Q,TI12Q,COR,Pr/PI,Pr/PI,1.25E-09,1.25e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.145338115191384,2.221638156056997,1R0R,1R0R_TI12Q,I,T12Q
1R0R_E_I,TI17E,TI12E,COR,Pr/PI,Pr/PI,6.67E-09,6.67e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.153291304415047,3.213684966833334,1R0R,1R0R_TI12E,I,T12E
1R0R_E_I,TI17H,TI12H,COR,Pr/PI,Pr/PI,7.14E-11,7.14e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.841291733184503,0.5256845380638762,1R0R,1R0R_TI12H,I,T12H
1R0R_E_I,TI17F,TI12F,COR,Pr/PI,Pr/PI,2.63E-11,2.63e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.432990669085004,-0.0660143978366214,1R0R,1R0R_TI12F,I,T12F
1R0R_E_I,TI17R,TI12R,COR,Pr/PI,Pr/PI,8.33E-09,8.33e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.021622644940807,3.345353626307574,1R0R,1R0R_TI12R,I,T12R
1R0R_E_I,TI17Y,TI12Y,COR,Pr/PI,Pr/PI,6.67E-12,6.67e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.245804622691038,-0.8788283514426567,1R0R,1R0R_TI12Y,I,T12Y
1R0R_E_I,TI17W,TI12W,COR,Pr/PI,Pr/PI,4.17E-09,4.17e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.431568266786895,2.935408004461486,1R0R,1R0R_TI12W,I,T12W
1R0R_E_I,EI19G,EI14G,COR,Pr/PI,Pr/PI,2.86E-09,2.86e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.654978598631509,2.7119976726168726,1R0R,1R0R_EI14G,I,E14G
1R0R_E_I,EI19A,EI14A,COR,Pr/PI,Pr/PI,1E-09,1e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.277539954827974,2.0894363164204077,1R0R,1R0R_EI14A,I,E14A
1R0R_E_I,EI19S,EI14S,COR,Pr/PI,Pr/PI,6.25E-09,6.25e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.19182343125119,3.1751528399971907,1R0R,1R0R_EI14S,I,E14S
1R0R_E_I,EI19C,EI14C,COR,Pr/PI,Pr/PI,1.61E-09,1.61e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.99539407075316,2.3715822004952223,1R0R,1R0R_EI14C,I,E14C
1R0R_E_I,EI19V,EI14V,COR,Pr/PI,Pr/PI,3.45E-11,3.45e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.272204897208464,0.0947713740399187,1R0R,1R0R_EI14V,I,E14V
1R0R_E_I,EI19T,EI14T,COR,Pr/PI,Pr/PI,3.85E-08,3.85e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.114700237788938,4.252276033459443,1R0R,1R0R_EI14T,I,E14T
1R0R_E_I,EI19P,EI14P,COR,Pr/PI,Pr/PI,1.69E-08,1.69e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.60249239083948,3.7644838804089016,1R0R,1R0R_EI14P,I,E14P
1R0R_E_I,EI19L,EI14L,COR,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_EI14L,I,E14L
1R0R_E_I,EI19I,EI14I,COR,Pr/PI,Pr/PI,1.02E-10,1.02e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.629978955094936,0.7369973161534453,1R0R,1R0R_EI14I,I,E14I
1R0R_E_I,EI19M,EI14M,COR,Pr/PI,Pr/PI,4.17E-10,4.17e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.795739372878892,1.571236898369488,1R0R,1R0R_EI14M,I,E14M
1R0R_E_I,EI19N,EI14N,COR,Pr/PI,Pr/PI,1.05E-09,1.05e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.24863412527842,2.11834214596996,1R0R,1R0R_EI14N,I,E14N
1R0R_E_I,EI19D,EI14D,COR,Pr/PI,Pr/PI,4.55E-11,4.55e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.108242032213097,0.2587342390352862,1R0R,1R0R_EI14D,I,E14D
1R0R_E_I,EI19K,EI14K,COR,Pr/PI,Pr/PI,2.86E-09,2.86e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.654978598631509,2.7119976726168726,1R0R,1R0R_EI14K,I,E14K
1R0R_E_I,EI19Q,EI14Q,COR,Pr/PI,Pr/PI,2.56E-10,2.56e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.084801895889546,1.282174375358835,1R0R,1R0R_EI14Q,I,E14Q
1R0R_E_I,EI19H,EI14H,COR,Pr/PI,Pr/PI,5.26E-10,5.26e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.658163140841202,1.7088131304071794,1R0R,1R0R_EI14H,I,E14H
1R0R_E_I,EI19F,EI14F,COR,Pr/PI,Pr/PI,1.32E-08,1.32e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.748885375637032,3.618090895611349,1R0R,1R0R_EI14F,I,E14F
1R0R_E_I,EI19R,EI14R,COR,Pr/PI,Pr/PI,1E-09,1e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.277539954827974,2.0894363164204077,1R0R,1R0R_EI14R,I,E14R
1R0R_E_I,EI19Y,EI14Y,COR,Pr/PI,Pr/PI,7.14E-10,7.14e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.477120627092509,1.8898556441558745,1R0R,1R0R_EI14Y,I,E14Y
1R0R_E_I,EI19W,EI14W,COR,Pr/PI,Pr/PI,6.67E-10,6.67e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P1'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.517462410507042,1.8495138607413395,1R0R,1R0R_EI14W,I,E14W
1R0R_E_I,YI20G,YI15G,COR,Pr/PI,Pr/PI,1.45E-06,1.45e-06,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-7.964893070455242,6.40208320079314,1R0R,1R0R_YI15G,I,Y15G
1R0R_E_I,YI20A,YI15A,COR,Pr/PI,Pr/PI,3.03E-07,3.03e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.892427619600152,5.474548651648229,1R0R,1R0R_YI15A,I,Y15A
1R0R_E_I,YI20S,YI15S,COR,Pr/PI,Pr/PI,1.79E-07,1.79e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.204262943693424,5.1627133275549575,1R0R,1R0R_YI15S,I,Y15S
1R0R_E_I,YI20C,YI15C,COR,Pr/PI,Pr/PI,7.14E-09,7.14e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.11294952100051,3.2540267502478706,1R0R,1R0R_YI15C,I,Y15C
1R0R_E_I,YI20V,YI15V,COR,Pr/PI,Pr/PI,1.1E-08,1.1e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.856902143639564,3.510074127608817,1R0R,1R0R_YI15V,I,Y15V
1R0R_E_I,YI20T,YI15T,COR,Pr/PI,Pr/PI,3.03E-07,3.03e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.892427619600152,5.474548651648229,1R0R,1R0R_YI15T,I,Y15T
1R0R_E_I,YI20P,YI15P,COR,Pr/PI,Pr/PI,2.22E-06,2.22e-06,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-7.712541916297401,6.65443435495098,1R0R,1R0R_YI15P,I,Y15P
1R0R_E_I,YI20L,YI15L,COR,Pr/PI,Pr/PI,2.27E-09,2.27e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.79185976742348,2.5751165038249013,1R0R,1R0R_YI15L,I,Y15L
1R0R_E_I,YI20I,YI15I,COR,Pr/PI,Pr/PI,3.7E-09,3.7e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.502415580424122,2.864560690824259,1R0R,1R0R_YI15I,I,Y15I
1R0R_E_I,YI20M,YI15M,COR,Pr/PI,Pr/PI,5.88E-09,5.88e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.227977636912586,3.1389986343357954,1R0R,1R0R_YI15M,I,Y15M
1R0R_E_I,YI20N,YI15N,COR,Pr/PI,Pr/PI,3.85E-07,3.85e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.750529131696942,5.61644713955144,1R0R,1R0R_YI15N,I,Y15N
1R0R_E_I,YI20D,YI15D,COR,Pr/PI,Pr/PI,5E-07,5e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.595683058703784,5.771293212544597,1R0R,1R0R_YI15D,I,Y15D
1R0R_E_I,YI20K,YI15K,COR,Pr/PI,Pr/PI,3.23E-07,3.23e-07,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-8.854558374530725,5.512417896717656,1R0R,1R0R_YI15K,I,Y15K
1R0R_E_I,YI20Q,YI15Q,COR,Pr/PI,Pr/PI,5.88E-08,5.88e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.863806530820588,4.5031697404277935,1R0R,1R0R_YI15Q,I,Y15Q
1R0R_E_I,YI20E,YI15E,COR,Pr/PI,Pr/PI,7.14E-08,7.14e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.748778414908513,4.618197856339869,1R0R,1R0R_YI15E,I,Y15E
1R0R_E_I,YI20H,YI15H,COR,Pr/PI,Pr/PI,1.03E-08,1.03e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.895856677710771,3.47111959353761,1R0R,1R0R_YI15H,I,Y15H
1R0R_E_I,YI20F,YI15F,COR,Pr/PI,Pr/PI,8.33E-11,8.33e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.749964857124803,0.6170114141235779,1R0R,1R0R_YI15F,I,Y15F
1R0R_E_I,YI20R,YI15R,COR,Pr/PI,Pr/PI,5.56E-08,5.56e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-9.896959346182216,4.470016925066165,1R0R,1R0R_YI15R,I,Y15R
1R0R_E_I,YI20W,YI15W,COR,Pr/PI,Pr/PI,1.59E-11,1.59e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P2'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.73114202916399,-0.3641657579156092,1R0R,1R0R_YI15W,I,Y15W
1R0R_E_I,RI21G,RI16G,RIM,Pr/PI,Pr/PI,1E-09,1e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.277539954827974,2.0894363164204077,1R0R,1R0R_RI16G,I,R16G
1R0R_E_I,RI21A,RI16A,RIM,Pr/PI,Pr/PI,2.5E-11,2.5e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.463023905223576,-0.0960476339751945,1R0R,1R0R_RI16A,I,R16A
1R0R_E_I,RI21S,RI16S,RIM,Pr/PI,Pr/PI,2.86E-11,2.86e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.383320810815505,-0.0163445395671235,1R0R,1R0R_RI16S,I,R16S
1R0R_E_I,RI21C,RI16C,RIM,Pr/PI,Pr/PI,3.57E-11,3.57e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.251948155336306,0.1150281159120751,1R0R,1R0R_RI16C,I,R16C
1R0R_E_I,RI21V,RI16V,RIM,Pr/PI,Pr/PI,3.57E-11,3.57e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.251948155336306,0.1150281159120751,1R0R,1R0R_RI16V,I,R16V
1R0R_E_I,RI21T,RI16T,RIM,Pr/PI,Pr/PI,5.26E-11,5.26e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.0223342469332,0.3446420243151813,1R0R,1R0R_RI16T,I,R16T
1R0R_E_I,RI21P,RI16P,RIM,Pr/PI,Pr/PI,7.69E-06,7.69e-06,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-6.976471521669031,7.3905047495793506,1R0R,1R0R_RI16P,I,R16P
1R0R_E_I,RI21L,RI16L,RIM,Pr/PI,Pr/PI,4.35E-11,4.35e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.134873571124302,0.2321027001240789,1R0R,1R0R_RI16L,I,R16L
1R0R_E_I,RI21I,RI16I,RIM,Pr/PI,Pr/PI,4.17E-11,4.17e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.159910478970888,0.2070657922774934,1R0R,1R0R_RI16I,I,R16I
1R0R_E_I,RI21M,RI16M,RIM,Pr/PI,Pr/PI,6.25E-11,6.25e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.920165643435183,0.446810627813198,1R0R,1R0R_RI16M,I,R16M
1R0R_E_I,RI21N,RI16N,RIM,Pr/PI,Pr/PI,2.7E-11,2.7e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.417428183731197,-0.0504519124828135,1R0R,1R0R_RI16N,I,R16N
1R0R_E_I,RI21D,RI16D,RIM,Pr/PI,Pr/PI,2.17E-11,2.17e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.5468935197324,-0.1799172484840188,1R0R,1R0R_RI16D,I,R16D
1R0R_E_I,RI21K,RI16K,RIM,Pr/PI,Pr/PI,2.5E-11,2.5e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.463023905223576,-0.0960476339751945,1R0R,1R0R_RI16K,I,R16K
1R0R_E_I,RI21Q,RI16Q,RIM,Pr/PI,Pr/PI,4E-11,4e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.184569322708365,0.1824069485400183,1R0R,1R0R_RI16Q,I,R16Q
1R0R_E_I,RI21E,RI16E,RIM,Pr/PI,Pr/PI,5.26E-11,5.26e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.0223342469332,0.3446420243151813,1R0R,1R0R_RI16E,I,R16E
1R0R_E_I,RI21H,RI16H,RIM,Pr/PI,Pr/PI,7.14E-11,7.14e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.841291733184503,0.5256845380638762,1R0R,1R0R_RI16H,I,R16H
1R0R_E_I,RI21F,RI16F,RIM,Pr/PI,Pr/PI,6.25E-11,6.25e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.920165643435183,0.446810627813198,1R0R,1R0R_RI16F,I,R16F
1R0R_E_I,RI21Y,RI16Y,RIM,Pr/PI,Pr/PI,1.18E-10,1.18e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.54365170350506,0.8233245677433221,1R0R,1R0R_RI16Y,I,R16Y
1R0R_E_I,RI21W,RI16W,RIM,Pr/PI,Pr/PI,1.45E-10,1.45e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P3'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.421577494823229,0.9453987764251526,1R0R,1R0R_RI16W,I,R16W
1R0R_E_I,PI14G,PI9G,RIM,Pr/PI,Pr/PI,1.64E-11,1.64e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.71279839718368,-0.3458221259352978,1R0R,1R0R_PI9G,I,P9G
1R0R_E_I,PI14A,PI9A,RIM,Pr/PI,Pr/PI,1E-11,1e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.005882167011968,-0.6389058957635854,1R0R,1R0R_PI9A,I,P9A
1R0R_E_I,PI14S,PI9S,RIM,Pr/PI,Pr/PI,3.7E-11,3.7e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.230757792608117,0.1362184786402664,1R0R,1R0R_PI9S,I,P9S
1R0R_E_I,PI14C,PI9C,RIM,Pr/PI,Pr/PI,5.56E-12,5.56e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.353643770550203,-0.9866674993018236,1R0R,1R0R_PI9C,I,P9C
1R0R_E_I,PI14V,PI9V,RIM,Pr/PI,Pr/PI,2.78E-10,2.78e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.035957980518011,1.331018290730368,1R0R,1R0R_PI9V,I,P9V
1R0R_E_I,PI14T,PI9T,RIM,Pr/PI,Pr/PI,2.22E-10,2.22e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.16922634066539,1.197749930582992,1R0R,1R0R_PI9T,I,P9T
1R0R_E_I,PI14L,PI9L,RIM,Pr/PI,Pr/PI,2.17E-10,2.17e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.182722413640402,1.1842538576079793,1R0R,1R0R_PI9L,I,P9L
1R0R_E_I,PI14I,PI9I,RIM,Pr/PI,Pr/PI,5.56E-10,5.56e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.625301558366212,1.741674712882169,1R0R,1R0R_PI9I,I,P9I
1R0R_E_I,PI14M,PI9M,RIM,Pr/PI,Pr/PI,2.78E-11,2.78e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.400129086610011,-0.03315281536163,1R0R,1R0R_PI9M,I,P9M
1R0R_E_I,PI14N,PI9N,RIM,Pr/PI,Pr/PI,6.25E-12,6.25e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.28433674952718,-0.9173604782788,1R0R,1R0R_PI9N,I,P9N
1R0R_E_I,PI14D,PI9D,RIM,Pr/PI,Pr/PI,4.17E-13,4.17e-13,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.888252691154886,-2.5212764199065045,1R0R,1R0R_PI9D,I,P9D
1R0R_E_I,PI14K,PI9K,RIM,Pr/PI,Pr/PI,5.26E-11,5.26e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.0223342469332,0.3446420243151813,1R0R,1R0R_PI9K,I,P9K
1R0R_E_I,PI14Q,PI9Q,RIM,Pr/PI,Pr/PI,2.7E-12,2.7e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.781599289823191,-1.4146230185748117,1R0R,1R0R_PI9Q,I,P9Q
1R0R_E_I,PI14E,PI9E,RIM,Pr/PI,Pr/PI,6.67E-13,6.67e-13,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-16.609975728783034,-2.242999457534653,1R0R,1R0R_PI9E,I,P9E
1R0R_E_I,PI14H,PI9H,RIM,Pr/PI,Pr/PI,2.04E-11,2.04e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.58349363903513,-0.2165173677867482,1R0R,1R0R_PI9H,I,P9H
1R0R_E_I,PI14F,PI9F,RIM,Pr/PI,Pr/PI,3.03E-10,3.03e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.984940937876145,1.3820353333722384,1R0R,1R0R_PI9F,I,P9F
1R0R_E_I,PI14R,PI9R,RIM,Pr/PI,Pr/PI,1.89E-10,1.89e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.264569855728768,1.1024064155196136,1R0R,1R0R_PI9R,I,P9R
1R0R_E_I,PI14Y,PI9Y,RIM,Pr/PI,Pr/PI,1.25E-10,1.25e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.50950922128338,0.8574670499650008,1R0R,1R0R_PI9Y,I,P9Y
1R0R_E_I,PI14W,PI9W,RIM,Pr/PI,Pr/PI,6.67E-11,6.67e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P5. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.88163351659904,0.4853427546493414,1R0R,1R0R_PI9W,I,P9W
1R0R_E_I,KI13G,KI8G,COR,Pr/PI,Pr/PI,7.14E-12,7.14e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.2054628392765,-0.8384865680281202,1R0R,1R0R_KI8G,I,K8G
1R0R_E_I,KI13A,KI8A,COR,Pr/PI,Pr/PI,1.05E-11,1.05e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.976976337462416,-0.6100000662140346,1R0R,1R0R_KI8A,I,K8A
1R0R_E_I,KI13S,KI8S,COR,Pr/PI,Pr/PI,1.75E-11,1.75e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.674336683313143,-0.3073604120647637,1R0R,1R0R_KI8S,I,K8S
1R0R_E_I,KI13C,KI8C,COR,Pr/PI,Pr/PI,1.04E-11,1.04e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.98264577770031,-0.615669506451928,1R0R,1R0R_KI8C,I,K8C
1R0R_E_I,KI13V,KI8V,COR,Pr/PI,Pr/PI,5.88E-11,5.88e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.95631984909658,0.4106564221518027,1R0R,1R0R_KI8V,I,K8V
1R0R_E_I,KI13T,KI8T,COR,Pr/PI,Pr/PI,1.32E-10,1.32e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.477227587821028,0.8897486834273547,1R0R,1R0R_KI8T,I,K8T
1R0R_E_I,KI13P,KI8P,COR,Pr/PI,Pr/PI,2.86E-10,2.86e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.019149704723509,1.3478265665248743,1R0R,1R0R_KI8P,I,K8P
1R0R_E_I,KI13L,KI8L,COR,Pr/PI,Pr/PI,1.69E-11,1.69e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.695005709115472,-0.3280294378670909,1R0R,1R0R_KI8L,I,K8L
1R0R_E_I,KI13I,KI8I,COR,Pr/PI,Pr/PI,1.96E-10,1.96e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.243023772795503,1.1239524984528764,1R0R,1R0R_KI8I,I,K8I
1R0R_E_I,KI13M,KI8M,COR,Pr/PI,Pr/PI,1.14E-11,1.14e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.928254213022292,-0.5612779417739109,1R0R,1R0R_KI8M,I,K8M
1R0R_E_I,KI13N,KI8N,COR,Pr/PI,Pr/PI,1.52E-11,1.52e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.757816398509611,-0.3908401272612298,1R0R,1R0R_KI8N,I,K8N
1R0R_E_I,KI13D,KI8D,COR,Pr/PI,Pr/PI,1.08E-11,1.08e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.960286445519587,-0.5933101742712061,1R0R,1R0R_KI8D,I,K8D
1R0R_E_I,KI13Q,KI8Q,COR,Pr/PI,Pr/PI,1.2E-11,1.2e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.897865399009437,-0.5308891277610552,1R0R,1R0R_KI8Q,I,K8Q
1R0R_E_I,KI13E,KI8E,COR,Pr/PI,Pr/PI,2.44E-11,2.44e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.477416159126678,-0.1104398878782966,1R0R,1R0R_KI8E,I,K8E
1R0R_E_I,KI13H,KI8H,COR,Pr/PI,Pr/PI,1.08E-11,1.08e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.960286445519587,-0.5933101742712061,1R0R,1R0R_KI8H,I,K8H
1R0R_E_I,KI13F,KI8F,COR,Pr/PI,Pr/PI,7.69E-12,7.69e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.161498158221011,-0.7945218869726318,1R0R,1R0R_KI8F,I,K8F
1R0R_E_I,KI13R,KI8R,COR,Pr/PI,Pr/PI,3.7E-11,3.7e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.230757792608117,0.1362184786402664,1R0R,1R0R_KI8R,I,K8R
1R0R_E_I,KI13Y,KI8Y,COR,Pr/PI,Pr/PI,9.09E-12,9.09e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.062408120269216,-0.6954318490208333,1R0R,1R0R_KI8Y,I,K8Y
1R0R_E_I,KI13W,KI8W,COR,Pr/PI,Pr/PI,4.55E-12,4.55e-12,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P6. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-15.472413138305091,-1.1054368670567118,1R0R,1R0R_KI8W,I,K8W
1R0R_E_I,GI32A,GI27A,SUP,Pr/PI,Pr/PI,2.63E-10,2.63e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.068819562993006,1.2981567082553749,1R0R,1R0R_GI27A,I,G27A
1R0R_E_I,GI32S,GI27S,SUP,Pr/PI,Pr/PI,1.37E-10,1.37e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.45520081359669,0.9117754576516912,1R0R,1R0R_GI27S,I,G27S
1R0R_E_I,GI32C,GI27C,SUP,Pr/PI,Pr/PI,3.23E-10,3.23e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.947071692806714,1.4199045784416668,1R0R,1R0R_GI27C,I,G27C
1R0R_E_I,GI32V,GI27V,SUP,Pr/PI,Pr/PI,7.69E-10,7.69e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.433155946037015,1.9338203252113644,1R0R,1R0R_GI27V,I,G27V
1R0R_E_I,GI32T,GI27T,SUP,Pr/PI,Pr/PI,5E-10,5e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.688196376979777,1.6787798942686063,1R0R,1R0R_GI27T,I,G27T
1R0R_E_I,GI32P,GI27P,SUP,Pr/PI,Pr/PI,1.82E-10,1.82e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.286929187909491,1.08004708333889,1R0R,1R0R_GI27P,I,G27P
1R0R_E_I,GI32L,GI27L,SUP,Pr/PI,Pr/PI,1.72E-09,1.72e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.956238852893971,2.41073741835441,1R0R,1R0R_GI27L,I,G27L
1R0R_E_I,GI32I,GI27I,SUP,Pr/PI,Pr/PI,8.33E-10,8.33e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.385793751032804,1.981182520215576,1R0R,1R0R_GI27I,I,G27I
1R0R_E_I,GI32M,GI27M,SUP,Pr/PI,Pr/PI,1.12E-09,1.12e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.21039815040233,2.156578120846051,1R0R,1R0R_GI27M,I,G27M
1R0R_E_I,GI32N,GI27N,SUP,Pr/PI,Pr/PI,2.56E-10,2.56e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.084801895889546,1.282174375358835,1R0R,1R0R_GI27N,I,G27N
1R0R_E_I,GI32D,GI27D,SUP,Pr/PI,Pr/PI,3.85E-09,3.85e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.478871343880934,2.888104927367447,1R0R,1R0R_GI27D,I,G27D
1R0R_E_I,GI32K,GI27K,SUP,Pr/PI,Pr/PI,4.17E-09,4.17e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-11.431568266786895,2.935408004461486,1R0R,1R0R_GI27K,I,G27K
1R0R_E_I,GI32Q,GI27Q,SUP,Pr/PI,Pr/PI,9.09E-10,9.09e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.33406590808522,2.032910363163161,1R0R,1R0R_GI27Q,I,G27Q
1R0R_E_I,GI32E,GI27E,SUP,Pr/PI,Pr/PI,8.33E-10,8.33e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.385793751032804,1.981182520215576,1R0R,1R0R_GI27E,I,G27E
1R0R_E_I,GI32H,GI27H,SUP,Pr/PI,Pr/PI,1.19E-09,1.19e-09,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.174480972943236,2.192495298305145,1R0R,1R0R_GI27H,I,G27H
1R0R_E_I,GI32F,GI27F,SUP,Pr/PI,Pr/PI,3.57E-11,3.57e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.251948155336306,0.1150281159120751,1R0R,1R0R_GI27F,I,G27F
1R0R_E_I,GI32R,GI27R,SUP,Pr/PI,Pr/PI,1.03E-08,1.03e-08,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-10.895856677710771,3.47111959353761,1R0R,1R0R_GI27R,I,G27R
1R0R_E_I,GI32Y,GI27Y,SUP,Pr/PI,Pr/PI,6.67E-11,6.67e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.88163351659904,0.4853427546493414,1R0R,1R0R_GI27Y,I,G27Y
1R0R_E_I,GI32W,GI27W,SUP,Pr/PI,Pr/PI,3.13E-10,3.13e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P14'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.965703793851606,1.401272477396775,1R0R,1R0R_GI27W,I,G27W
1R0R_E_I,NI36G,NI31G,RIM,Pr/PI,Pr/PI,4.76E-11,4.76e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.081510340823623,0.2854659304247562,1R0R,1R0R_NI31G,I,N31G
1R0R_E_I,NI36A,NI31A,RIM,Pr/PI,Pr/PI,2.78E-11,2.78e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.400129086610011,-0.03315281536163,1R0R,1R0R_NI31A,I,N31A
1R0R_E_I,NI36S,NI31S,RIM,Pr/PI,Pr/PI,6.67E-11,6.67e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.88163351659904,0.4853427546493414,1R0R,1R0R_NI31S,I,N31S
1R0R_E_I,NI36C,NI31C,RIM,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_NI31C,I,N31C
1R0R_E_I,NI36V,NI31V,RIM,Pr/PI,Pr/PI,9.09E-11,9.09e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.698237014177217,0.6687392570711648,1R0R,1R0R_NI31V,I,N31V
1R0R_E_I,NI36T,NI31T,RIM,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_NI31T,I,N31T
1R0R_E_I,NI36P,NI31P,RIM,Pr/PI,Pr/PI,3.57E-10,3.57e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.88777704924431,1.4791992220040715,1R0R,1R0R_NI31P,I,N31P
1R0R_E_I,NI36L,NI31L,RIM,Pr/PI,Pr/PI,4E-10,4e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.820398216616368,1.5465780546320147,1R0R,1R0R_NI31L,I,N31L
1R0R_E_I,NI36I,NI31I,RIM,Pr/PI,Pr/PI,5E-11,5e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.052367483071771,0.3146087881766082,1R0R,1R0R_NI31I,I,N31I
1R0R_E_I,NI36M,NI31M,RIM,Pr/PI,Pr/PI,5E-11,5e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.052367483071771,0.3146087881766082,1R0R,1R0R_NI31M,I,N31M
1R0R_E_I,NI36D,NI31D,RIM,Pr/PI,Pr/PI,7.69E-11,7.69e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.797327052129017,0.5696492191193663,1R0R,1R0R_NI31D,I,N31D
1R0R_E_I,NI36K,NI31K,RIM,Pr/PI,Pr/PI,2.04E-10,2.04e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-13.219322532943131,1.14765373830525,1R0R,1R0R_NI31K,I,N31K
1R0R_E_I,NI36Q,NI31Q,RIM,Pr/PI,Pr/PI,1.85E-11,1.85e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.641414214759918,-0.2744379435115363,1R0R,1R0R_NI31Q,I,N31Q
1R0R_E_I,NI36E,NI31E,RIM,Pr/PI,Pr/PI,2.08E-11,2.08e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.571989355548508,-0.205013084300127,1R0R,1R0R_NI31E,I,N31E
1R0R_E_I,NI36H,NI31H,RIM,Pr/PI,Pr/PI,4.76E-11,4.76e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.081510340823623,0.2854659304247562,1R0R,1R0R_NI31H,I,N31H
1R0R_E_I,NI36F,NI31F,RIM,Pr/PI,Pr/PI,2.17E-11,2.17e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.5468935197324,-0.1799172484840188,1R0R,1R0R_NI31F,I,N31F
1R0R_E_I,NI36R,NI31R,RIM,Pr/PI,Pr/PI,3.45E-10,3.45e-10,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-12.908033791116464,1.4589424801319169,1R0R,1R0R_NI31R,I,N31R
1R0R_E_I,NI36Y,NI31Y,RIM,Pr/PI,Pr/PI,4E-11,4e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.184569322708365,0.1824069485400183,1R0R,1R0R_NI31Y,I,N31Y
1R0R_E_I,NI36W,NI31W,RIM,Pr/PI,Pr/PI,3.23E-11,3.23e-11,2.94E-11,2.94e-11,11171964,Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"P18'. Data was provided by Mohammad A Qasim.,,",FL,1,-14.36697627124838,-14.311242798898713,0.0557334723496687,1R0R,1R0R_NI31W,I,N31W
1F5R_A_I,KA156Q,KA129Q,INT,Pr/PI,Pr/PI,9E-06,9e-06,6.5E-05,6.5e-05,11420435,Mutant trypsinogen,BPTI,298,,,,,,,,,,,,,,ITC,1,-5.711902617571543,-6.883276576970135,-1.1713739593985926,1F5R,1F5R_KA129Q,A,K129Q
3BTM_E_I,MI515K,MI13K,COR,Pr/PI,Pr/PI,5.88E-14,5.88e-14,2.56E-08,2.56e-08,10339415,Bovine trypsin,BPTI,295,,,,,,,,,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",IASP,1,-10.356459683705552,-18.04883316737257,-7.692373483667019,3BTM,3BTM_MI13K,I,M13K
1KAC_A_B,PA417S,PA15S,COR,,"1KAC_A_B,1P69_A_B,1P6A_A_B,2J1K_C_T,2J12_A_B",7.6E-08,7.6e-08,2.9E-07,2.9e-07,12716886,AD12 knob protein,CAR D1 domain,298,,,,,,,,,,,,,,FL,1,-8.918407754395435,-9.711788396293423,-0.7933806418979898,1KAC,1KAC_PA15S,A,P15S
1KAC_A_B,SA489Y,SA87Y,RIM,,"1KAC_A_B,1P69_A_B,1P6A_A_B,2J1K_C_T,2J12_A_B",3.5E-08,3.5e-08,2.9E-07,2.9e-07,12716886,AD12 knob protein,CAR D1 domain,298,,,,,,,,,,,,,,FL,1,-8.918407754395435,-10.171166942885352,-1.2527591884899163,1KAC,1KAC_SA87Y,A,S87Y
1R0R_E_I,LI18M,LI13M,COR,Pr/PI,Pr/PI,1.23E-11,1.23e-11,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"OMTTR3,,",FL,1,-14.36697627124838,-14.88323621169636,-0.5162599404479788,1R0R,1R0R_LI13M,I,L13M
1R0R_E_I,GI32A,GI27A,SUP,Pr/PI,Pr/PI,2.78E-10,2.78e-10,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"OMCAQ3,,",FL,1,-14.36697627124838,-13.035957980518011,1.331018290730368,1R0R,1R0R_GI27A,I,G27A
1R0R_E_I,NI28S,NI23S,SUR,Pr/PI,Pr/PI,2.63E-11,2.63e-11,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"OMCHU3,,",FL,1,-14.36697627124838,-14.432990669085004,-0.0660143978366214,1R0R,1R0R_NI23S,I,N23S
1R0R_E_I,YI20H,YI15H,COR,Pr/PI,Pr/PI,5E-09,5e-09,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"OMIPF3,,",FL,1,-14.36697627124838,-11.32402527088778,3.0429510003606026,1R0R,1R0R_YI15H,I,Y15H
1R0R_E_I,GI32V,GI27V,SUP,Pr/PI,Pr/PI,8.33E-10,8.33e-10,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"HYBRID5,,",FL,1,-14.36697627124838,-12.385793751032804,1.981182520215576,1R0R,1R0R_GI27V,I,G27V
1R0R_E_I,YI20D,YI15D,COR,Pr/PI,Pr/PI,3.03E-07,3.03e-07,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"HYBRID6,,",FL,1,-14.36697627124838,-8.892427619600152,5.474548651648229,1R0R,1R0R_YI15D,I,Y15D
1R0R_E_I,TI17E,TI12E,COR,Pr/PI,Pr/PI,3.45E-09,3.45e-09,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY3,,",FL,1,-14.36697627124838,-11.54386268502447,2.8231135862239114,1R0R,1R0R_TI12E,I,T12E
1R0R_E_I,TI17S,TI12S,COR,Pr/PI,Pr/PI,1.19E-10,1.19e-10,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY5,,",FL,1,-14.36697627124838,-13.538652079035232,0.8283241922131488,1R0R,1R0R_TI12S,I,T12S
1R0R_E_I,TI17V,TI12V,COR,Pr/PI,Pr/PI,1.82E-10,1.82e-10,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY6,,",FL,1,-14.36697627124838,-13.286929187909491,1.08004708333889,1R0R,1R0R_TI12V,I,T12V
1R0R_E_I,AI15V,AI10V,COR,Pr/PI,Pr/PI,5.56E-12,5.56e-12,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY7,,",FL,1,-14.36697627124838,-15.353643770550203,-0.9866674993018236,1R0R,1R0R_AI10V,I,A10V
1R0R_E_I,TI17A,TI12A,COR,Pr/PI,Pr/PI,1.11E-10,1.11e-10,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY9,,",FL,1,-14.36697627124838,-13.579882762817192,0.7870935084311892,1R0R,1R0R_TI12A,I,T12A
1R0R_E_I,LI18K,LI13K,COR,Pr/PI,Pr/PI,3.57E-09,3.57e-09,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY10,,",FL,1,-14.36697627124838,-11.523605943152312,2.8433703280960696,1R0R,1R0R_LI13K,I,L13K
1R0R_E_I,LI18A,LI13A,COR,Pr/PI,Pr/PI,7.14E-11,7.14e-11,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY11,,",FL,1,-14.36697627124838,-13.841291733184503,0.5256845380638762,1R0R,1R0R_LI13A,I,L13A
1R0R_E_I,LI18E,LI13E,COR,Pr/PI,Pr/PI,1.06E-09,1.06e-09,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY12,,",FL,1,-14.36697627124838,-12.243018424619118,2.1239578466292635,1R0R,1R0R_LI13E,I,L13E
1R0R_E_I,LI18Q,LI13Q,COR,Pr/PI,Pr/PI,8.33E-11,8.33e-11,2.94E-11,2.94e-11,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000",Subtilisin Carlsberg,Turkey ovomucoid third domain,294,,,,,,,,,,,,,"SEMSY16,,",FL,1,-14.36697627124838,-13.749964857124803,0.6170114141235779,1R0R,1R0R_LI13Q,I,L13Q
5F4E_A_B,EA71A,EA50A,RIM,,5F4E_A_B,9.6E-08,9.6e-08,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,143000.0,143000.0,115000.0,115000.0,1.37E-02,0.0137,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.57338281427804,0.2884119931028337,5F4E,5F4E_EA50A,A,E50A
5F4E_A_B,EA71K,EA50K,RIM,,5F4E_A_B,1.19E-07,1.19e-07,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,165000.0,165000.0,115000.0,115000.0,1.95E-02,0.0195,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.446138760759242,0.4156560466216312,5F4E,5F4E_EA50K,A,E50K
5F4E_A_B,DA72A,DA51A,SUR,,5F4E_A_B,7.1E-08,7.1e-08,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,178000.0,178000.0,115000.0,115000.0,1.26E-02,0.0126,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.75210680559383,0.1096880017870436,5F4E,5F4E_DA51A,A,D51A
5F4E_A_B,QA130A,QA109A,INT,,5F4E_A_B,5.6E-08,5.6e-08,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,127000.0,127000.0,115000.0,115000.0,6.8E-03,0.0068,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.89271236037014,-0.0309175529892655,5F4E,5F4E_QA109A,A,Q109A
5F4E_A_B,HA157A,HA136A,COR,,5F4E_A_B,1.8E-06,1.8e-06,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,51000.0,51000.0,115000.0,115000.0,7.9E-02,0.079,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-7.83679126091033,2.0250035464705425,5F4E,5F4E_HA136A,A,H136A
5F4E_A_B,RA160A,RA139A,COR,,5F4E_A_B,7.3E-07,7.3e-07,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,78000.0,78000.0,115000.0,115000.0,5.63E-02,0.0563,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-8.37147764163895,1.4903171657419223,5F4E,5F4E_RA139A,A,R139A
5F4E_A_B,RA160E,RA139E,COR,,5F4E_A_B,2.2E-06,2.2e-06,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,32000.0,32000.0,115000.0,115000.0,5.12E-02,0.0512,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-7.717903509303766,2.143891298077107,5F4E,5F4E_RA139E,A,R139E
5F4E_A_B,EB45A,EB26A,COR,,5F4E_A_B,6.81E-07,6.81e-07,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,37000.0,37000.0,115000.0,115000.0,2.47E-02,0.0247,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-8.412642525448563,1.4491522819323102,5F4E,5F4E_EB26A,B,E26A
5F4E_A_B,EB45K,EB26K,COR,,5F4E_A_B,2.8E-06,2.8e-06,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,23000.0,23000.0,115000.0,115000.0,6.24E-02,0.0624,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-7.575026570337948,2.286768237042925,5F4E,5F4E_EB26K,B,E26K
5F4E_A_B,WB62A,WB43A,COR,,5F4E_A_B,3.61E-07,3.61e-07,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,114000.0,114000.0,115000.0,115000.0,4.12E-02,0.0412,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-8.788662526366084,1.0731322810147894,5F4E,5F4E_WB43A,B,W43A
5F4E_A_B,LB81A,LB62A,COR,,5F4E_A_B,9.1E-06,9.1e-06,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,40000.0,40000.0,115000.0,115000.0,3.49E-01,0.349,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-6.876730079601307,2.985064727779566,5F4E,5F4E_LB62A,B,L62A
5F4E_A_B,KB163A,KB139A,RIM,,5F4E_A_B,9.7E-08,9.7e-08,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,138000.0,138000.0,115000.0,115000.0,1.33E-02,0.0133,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.567243360541676,0.294551446839197,5F4E,5F4E_KB139A,B,K139A
5F4E_A_B,KB163E,KB139E,RIM,,5F4E_A_B,1.34E-07,1.34e-07,5.9E-08,5.9e-08,27309818,Sperm-egg fusion protein Izumo,Sperm-egg fusion protein Juno,293,181000.0,181000.0,115000.0,115000.0,2.42E-02,0.0242,6.7E-03,0.0067,,,,,,BI,2,-9.861794807380871,-9.37580504926906,0.4859897581118133,5F4E,5F4E_KB139E,B,K139E
4WND_A_B,RA221E,RA201E,SUP,,"4WND_A_B,3SF4_A_D,4G2V_A_B",6.5E-06,6.5e-06,5.8E-08,5.8e-08,22074847,G-protein-signaling modulator 2 (LGN),FERM and PDZ domain-containing protein 4 (FRMPD4),298,,,,,,,,,,,,,,SPR,2,-9.87192243833563,-7.076073723663541,2.79584871467209,4WND,4WND_RA201E,A,R201E
4WND_A_B,NA283R,NA263R,COR,,"4WND_A_B,3SF4_A_D,4G2V_A_B",5.6E-08,5.6e-08,5.8E-08,5.8e-08,22074847,G-protein-signaling modulator 2 (LGN),FERM and PDZ domain-containing protein 4 (FRMPD4),298,,,,,,,,,,,,,,SPR,2,-9.87192243833563,-9.89271236037014,-0.020789922034508,4WND,4WND_NA263R,A,N263R
1LP9_ABC_EF,TA163A,TA163A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.7E-06,4.7e-06,9.3E-06,9.3e-06,17825839,HLA-A2 plus P1049 peptide,AHIII TCR,298(assumed),33000.0,33000.0,31000.0,31000.0,1.6E-01,0.16,2.7E-01,0.27,,,,,,SPR,2,-6.863850181391922,-7.268170158289753,-0.4043199768978311,1LP9,1LP9_TA163A,A,T163A
1LP9_ABC_EF,WA167A,WA167A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.54E-05,1.54e-05,9.3E-06,9.3e-06,17825839,HLA-A2 plus P1049 peptide,AHIII TCR,298(assumed),41000.0,41000.0,31000.0,31000.0,6.3E-01,0.63,2.7E-01,0.27,,,,,,SPR,2,-6.863850181391922,-6.56504518130134,0.2988050000905824,1LP9,1LP9_WA167A,A,W167A
1LP9_ABC_EF,KA66A,KA66A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.18E-05,3.18e-05,9.3E-06,9.3e-06,17825839,HLA-A2 plus P1049 peptide,AHIII TCR,298(assumed),4700.0,4700.0,31000.0,31000.0,1.5E-01,0.15,2.7E-01,0.27,,,,,,SPR,2,-6.863850181391922,-6.1354589704602045,0.7283912109317177,1LP9,1LP9_KA66A,A,K66A
2JCC_ABC_EF,AA167W,AA167W,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9.3E-06,9.3e-06,1.54E-05,1.54e-05,17825839,HLA-A2 plus P1049 peptide,AHIII TCR,298(assumed),31000.0,31000.0,41000.0,41000.0,2.7E-01,0.27,6.3E-01,0.63,,,,,"Crystal structure is one of the mutants in the paper. This mutant is taken as 'wild-type',,",SPR,2,-6.56504518130134,-6.863850181391922,-0.2988050000905824,2JCC,2JCC_AA167W,A,A167W
1LP9_ABC_EF,KA66A,KA66A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,1E-06,1e-06,17825839,HLA-A2 plus P1049 peptide,AHIII TCR,298,,,,,,,,,-0.6,-3.9,21.1,14.8,,ITC,2,-8.185026636551983,-7.032168308549555,1.152858328002428,1LP9,1LP9_KA66A,A,K66A
3UII_A_P,KA62A,KA58A,RIM,,"3UII_A_P,3UIG_A_P,3UIH_A_P",1.08E-05,1.08e-05,1E-05,1e-05,22244766,Survivin,Histone H3(1-10) peptide,298,,,,,,,,,-7.71,-5.51,-3.11,4.38,,ITC,2,-6.820855530459986,-6.775259808967605,0.045595721492381,3UII,3UII_KA58A,A,K58A
4I77_HL_Z,YH97F,YH100F,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH100F,H,Y100F
4I77_HL_Z,YH97A,YH100A,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH100A,H,Y100A
4I77_HL_Z,YH98F,YH101F,COR,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH101F,H,Y101F
4I77_HL_Z,YH98A,YH101A,COR,AB/AG,AB/AG,4.9E-11,4.9e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-14.06433661709911,0.9415455499128562,4I77,4I77_YH101A,H,Y101A
4I77_HL_Z,YH100F,YH103F,COR,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH103F,H,Y103F
4I77_HL_Z,YH100A,YH103A,COR,AB/AG,AB/AG,1.74E-10,1.74e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-13.3135607268207,1.692321440191268,4I77,4I77_YH103A,H,Y103A
4I77_HL_Z,DH54A,DH54A,RIM,AB/AG,AB/AG,3.61E-10,3.61e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.881175844642076,2.1247063223698905,4I77,4I77_DH54A,H,D54A
4I77_HL_Z,WH52F,WH52F,SUP,AB/AG,AB/AG,3.46E-10,3.46e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.90631902296207,2.099563144049897,4I77,4I77_WH52F,H,W52F
4I77_HL_Z,WH52A,WH52A,SUP,AB/AG,AB/AG,3.55E-10,3.55e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.891105439929628,2.11477672708234,4I77,4I77_WH52A,H,W52A
4I77_HL_Z,YL28F,YL32F,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YL32F,L,Y32F
4I77_HL_Z,YL28A,YL32A,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YL32A,L,Y32A
4I77_HL_Z,NL91A,NL95A,SUP,AB/AG,AB/AG,1.83E-10,1.83e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,298,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-13.28368286754736,1.7221992994646058,4I77,4I77_NL95A,L,N95A
4I77_HL_Z,YH97F,YH100F,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH100F,H,Y100F
4I77_HL_Z,YH97A,YH100A,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH100A,H,Y100A
4I77_HL_Z,YH98F,YH101F,COR,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YH101F,H,Y101F
4I77_HL_Z,YH98A,YH101A,COR,AB/AG,AB/AG,4.66E-10,4.66e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.72991830565266,2.2759638613593065,4I77,4I77_YH101A,H,Y101A
4I77_HL_Z,YH100F,YH103F,COR,AB/AG,AB/AG,2.9E-11,2.9e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-14.375092178763424,0.6307899882485426,4I77,4I77_YH103F,H,Y103F
4I77_HL_Z,YH100A,YH103A,COR,AB/AG,AB/AG,8.05E-10,8.05e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.40605049290496,2.5998316741070067,4I77,4I77_YH103A,H,Y103A
4I77_HL_Z,DH54A,DH54A,RIM,AB/AG,AB/AG,1.57E-09,1.57e-09,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.010299309317832,2.995582857694135,4I77,4I77_DH54A,H,D54A
4I77_HL_Z,WH52F,WH52F,SUP,AB/AG,AB/AG,1.17E-09,1.17e-09,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.184522772389876,2.8213593946220907,4I77,4I77_WH52F,H,W52F
4I77_HL_Z,WH52A,WH52A,SUP,AB/AG,AB/AG,1.36E-09,1.36e-09,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-12.095370034490257,2.91051213252171,4I77,4I77_WH52A,H,W52A
4I77_HL_Z,YL28F,YL32F,RIM,AB/AG,AB/AG,<1E-11,1e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-15.005882167011968,0.0,4I77,4I77_YL32F,L,Y32F
4I77_HL_Z,YL28A,YL32A,RIM,AB/AG,AB/AG,1.41E-10,1.41e-10,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-13.438150658958817,1.56773150805315,4I77,4I77_YL32A,L,Y32A
4I77_HL_Z,NL91A,NL95A,SUP,AB/AG,AB/AG,5.4E-11,5.4e-11,<1E-11,1e-11,23357170,Lebrikizumab fab,Interleukin-13,310,,,,,,,,,,,,,,SPR,2,-15.005882167011968,-14.006771761579394,0.9991104054325728,4I77,4I77_NL95A,L,N95A
3S9D_A_B,SA25A,SA18A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",7E-09,7e-09,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,1.5E-02,0.015,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-11.124681626825549,-0.2113127780895709,3S9D,3S9D_SA18A,A,S18A
3S9D_A_B,LA26A,LA19A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5.5E-08,5.5e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,1.14E-01,0.114,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-9.903387459699369,1.009981389036609,3S9D,3S9D_LA19A,A,L19A
3S9D_A_B,FA27A,FA20A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.4E-08,2.4e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1900000.0,1900000.0,2100000.0,2100000.0,4.6E-02,0.046,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.394695658581645,0.5186731901543329,3S9D,3S9D_FA20A,A,F20A
3S9D_A_B,SA28A,SA21A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-08,1e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2300000.0,2300000.0,2100000.0,2100000.0,2.2E-02,0.022,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.913368848735976,0.0,3S9D,3S9D_SA21A,A,S21A
3S9D_A_B,LA30A,LA23A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-06,5e-06,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-7.231511952611788,3.681856896124188,3S9D,3S9D_LA23A,A,L23A
3S9D_A_B,KA31A,KA24A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.3E-08,2.3e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1300000.0,1300000.0,2100000.0,2100000.0,3E-02,0.03,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.419910186571592,0.4934586621643841,3S9D,3S9D_KA24A,A,K24A
3S9D_A_B,DA32A,DA25A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.9E-08,1.9e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,4.1E-02,0.041,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.533101240597029,0.3802676081389489,3S9D,3S9D_DA25A,A,D25A
3S9D_A_B,RA33A,RA26A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-06,5e-06,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-7.231511952611788,3.681856896124188,3S9D,3S9D_RA26A,A,R26A
3S9D_A_B,HA34A,HA27A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2E-08,2e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1800000.0,1800000.0,2100000.0,2100000.0,3.7E-02,0.037,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.502712426584177,0.410656422151801,3S9D,3S9D_HA27A,A,H27A
3S9D_A_B,DA35A,DA28A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.5E-08,1.5e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,3.1E-02,0.031,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.673150241096856,0.2402186076391199,3S9D,3S9D_DA28A,A,D28A
3S9D_A_B,EA41A,EA34A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-08,1e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,2.1E-02,0.021,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.913368848735976,0.0,3S9D,3S9D_EA34A,A,E34A
3S9D_A_B,KA121A,KA92A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.2E-08,1.2e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1900000.0,1900000.0,2100000.0,2100000.0,2.4E-02,0.024,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.805352080733446,0.1080167680025301,3S9D,3S9D_KA92A,A,K92A
3S9D_A_B,RA125A,RA96A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.8E-08,1.8e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1900000.0,1900000.0,2100000.0,2100000.0,3.4E-02,0.034,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.565133473094324,0.3482353756416518,3S9D,3S9D_RA96A,A,R96A
3S9D_A_B,LA128A,LA99A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9E-09,9e-09,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,2.1E-02,0.021,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.975789895246129,-0.0624210465101509,3S9D,3S9D_LA99A,A,L99A
3S9D_A_B,KA131A,KA102A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.6E-08,1.6e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1400000.0,1400000.0,2100000.0,2100000.0,2.3E-02,0.023,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.634914266220765,0.2784545825152111,3S9D,3S9D_KA102A,A,K102A
3S9D_A_B,EA132A,EA103A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8E-09,8e-09,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2400000.0,2400000.0,2100000.0,2100000.0,1.9E-02,0.019,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-11.045570688372568,-0.1322018396365916,3S9D,3S9D_EA103A,A,E103A
3S9D_A_B,KA133A,KA104A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.7E-08,3.7e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),900000.0,900000.0,2100000.0,2100000.0,3.3E-02,0.033,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.138244474332124,0.7751243744038518,3S9D,3S9D_KA104A,A,K104A
3S9D_A_B,KA134A,KA105A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.1E-08,1.1e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1800000.0,1800000.0,2100000.0,2100000.0,2.1E-02,0.021,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.856902143639564,0.0564667050964118,3S9D,3S9D_KA105A,A,K105A
3S9D_A_B,TB44A,TB33A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.3E-07,1.3e-07,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-9.393759513695732,1.5196093350402435,3S9D,3S9D_TB33A,B,T33A
3S9D_A_B,MB46A,MB35A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-06,5e-06,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-7.231511952611788,3.681856896124188,3S9D,3S9D_MB35A,B,M35A
3S9D_A_B,SB47A,SB36A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.2E-08,2.2e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2100000.0,2100000.0,2100000.0,2100000.0,4.7E-02,0.047,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.44624572148776,0.4671231272482146,3S9D,3S9D_SB36A,B,S36A
3S9D_A_B,KB48A,KB37A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.7E-08,1.7e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2600000.0,2600000.0,2100000.0,2100000.0,5.3E-02,0.053,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.598997088761667,0.314371759974307,3S9D,3S9D_KB37A,B,K37A
3S9D_A_B,EB50R,EB39R,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-08,3e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1300000.0,1300000.0,2100000.0,2100000.0,4E-02,0.04,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.262493818945051,0.6508750297909227,3S9D,3S9D_EB39R,B,E39R
3S9D_A_B,EB50A,EB39A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.4E-08,1.4e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2200000.0,2200000.0,2100000.0,2100000.0,3.2E-02,0.032,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.714025204673744,0.1993436440622318,3S9D,3S9D_EB39A,B,E39A
3S9D_A_B,KB53A,KB42A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.9E-08,1.9e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1800000.0,1800000.0,2100000.0,2100000.0,3.4E-02,0.034,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.533101240597029,0.3802676081389489,3S9D,3S9D_KB42A,B,K42A
3S9D_A_B,WB72F,WB61F,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.4E-08,3.4e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1600000.0,1600000.0,2100000.0,2100000.0,5.5E-02,0.055,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.188340666609866,0.7250281821261098,3S9D,3S9D_WB61F,B,W61F
3S9D_A_B,SB74A,SB63A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.7E-08,1.7e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2000000.0,2000000.0,2100000.0,2100000.0,3.3E-02,0.033,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.598997088761667,0.314371759974307,3S9D,3S9D_SB63A,B,S63A
3S9D_A_B,HB76A,HB65A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.9E-08,2.9e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1900000.0,1900000.0,2100000.0,2100000.0,5.5E-02,0.055,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.282578860487432,0.6307899882485426,3S9D,3S9D_HB65A,B,H65A
3S9D_A_B,NB98A,NB85A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",7E-09,7e-09,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2200000.0,2200000.0,2100000.0,2100000.0,1.6E-02,0.016,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-11.124681626825549,-0.2113127780895709,3S9D,3S9D_NB85A,B,N85A
3S9D_A_B,WB100A,WB87A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.5E-08,3.5e-08,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1800000.0,1800000.0,2100000.0,2100000.0,6.3E-02,0.063,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.171166942885352,0.7422019058506244,3S9D,3S9D_WB87A,B,W87A
3S9D_A_B,DB138R,DB121R,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9E-09,9e-09,1E-08,1e-08,10556041,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),1800000.0,1800000.0,2100000.0,2100000.0,1.7E-02,0.017,2E-02,0.02,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-10.913368848735976,-10.975789895246129,-0.0624210465101509,3S9D,3S9D_DB121R,B,D121R
3S9D_A_B,LA15A,LA8A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.6E-08,2.6e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2800000.0,2800000.0,3700000.0,3700000.0,7.3E-02,0.073,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.347274197635926,1.2793907274011236,3S9D,3S9D_LA8A,A,L8A
3S9D_A_B,MA16A,MA9A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.7E-09,3.7e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3700000.0,3700000.0,3700000.0,3700000.0,1.4E-02,0.014,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.502415580424122,0.1242493446129273,3S9D,3S9D_MA9A,A,M9A
3S9D_A_B,RA22A,RA15A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3700000.0,3700000.0,3700000.0,3700000.0,1.5E-02,0.015,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_RA15A,A,R15A
3S9D_A_B,RA23A,RA16A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5.5E-09,5.5e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3200000.0,3200000.0,3700000.0,3700000.0,1.8E-02,0.018,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.267558565791363,0.3591063592456844,3S9D,3S9D_RA16A,A,R16A
3S9D_A_B,IA24A,IA17A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.4E-09,2.4e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4600000.0,4600000.0,3700000.0,3700000.0,1.1E-02,0.011,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.75886676467364,-0.1322018396365916,3S9D,3S9D_IA17A,A,I17A
3S9D_A_B,SA25A,SA18A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.6E-09,2.6e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3200000.0,3200000.0,3700000.0,3700000.0,8E-03,0.008,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.711445303727924,-0.0847803786908745,3S9D,3S9D_SA18A,A,S18A
3S9D_A_B,LA26A,LA19A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.69E-08,1.69e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3000000.0,3000000.0,3700000.0,3700000.0,5E-02,0.05,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.60249239083948,1.0241725341975698,3S9D,3S9D_LA19A,A,L19A
3S9D_A_B,FA27A,FA20A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.37E-08,1.37e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2000000.0,2000000.0,3700000.0,3700000.0,2.7E-02,0.027,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.726858601412696,0.8998063236243521,3S9D,3S9D_FA20A,A,F20A
3S9D_A_B,LA30A,LA23A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.7E-06,1.7e-06,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-7.870654876577675,3.756010048459374,3S9D,3S9D_LA23A,A,L23A
3S9D_A_B,LA30V,LA23V,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.59E-07,2.59e-07,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-8.985386146329697,2.6412787787073526,3S9D,3S9D_LA23V,A,L23V
3S9D_A_B,KA31A,KA24A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9E-09,9e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2200000.0,2200000.0,3700000.0,3700000.0,2E-02,0.02,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.975789895246129,0.6508750297909227,3S9D,3S9D_KA24A,A,K24A
3S9D_A_B,DA32A,DA25A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.7E-09,8.7e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3000000.0,3000000.0,3700000.0,3700000.0,2.6E-02,0.026,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.995874936788509,0.6307899882485426,3S9D,3S9D_DA25A,A,D25A
3S9D_A_B,RA33K,RA26K,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8E-06,8e-06,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-6.953057370096575,4.6736075549404745,3S9D,3S9D_RA26K,A,R26K
3S9D_A_B,RA33A,RA26A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.81E-05,2.81e-05,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-6.208743333724603,5.417921591312447,3S9D,3S9D_RA26A,A,R26A
3S9D_A_B,RA33Q,RA26Q,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.62E-05,8.62e-05,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-5.544663548882787,6.082001376154262,3S9D,3S9D_RA26Q,A,R26Q
3S9D_A_B,HA34A,HA27A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",7.9E-09,7.9e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2400000.0,2400000.0,3700000.0,3700000.0,1.9E-02,0.019,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.05302301284415,0.5736419121928993,3S9D,3S9D_HA27A,A,H27A
3S9D_A_B,DA35A,DA28A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.6E-09,4.6e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4000000.0,4000000.0,3700000.0,3700000.0,1.8E-02,0.018,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.373424870511789,0.2532400545252624,3S9D,3S9D_DA28A,A,D28A
3S9D_A_B,QA40A,QA33A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.1E-09,3.1e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3900000.0,3900000.0,3700000.0,3700000.0,1.2E-02,0.012,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.607238529458836,0.019426395578213,3S9D,3S9D_QA33A,A,Q33A
3S9D_A_B,RA125A,RA96A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),5100000.0,5100000.0,3700000.0,3700000.0,1.6E-02,0.016,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_RA96A,A,R96A
3S9D_A_B,KA131A,KA102A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6.2E-09,6.2e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2000000.0,2000000.0,3700000.0,3700000.0,1.2E-02,0.012,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.196582107307034,0.4300828177300158,3S9D,3S9D_KA102A,A,K102A
3S9D_A_B,EA132A,EA103A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.1E-09,2.1e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),5200000.0,5200000.0,3700000.0,3700000.0,1.1E-02,0.011,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.83797770312662,-0.2113127780895709,3S9D,3S9D_EA103A,A,E103A
3S9D_A_B,KA133A,KA104A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.6E-08,2.6e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),700000.0,700000.0,3700000.0,3700000.0,1.8E-02,0.018,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.347274197635926,1.2793907274011236,3S9D,3S9D_KA104A,A,K104A
3S9D_A_B,KA134A,KA105A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.8E-09,3.8e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3600000.0,3600000.0,3700000.0,3700000.0,1.4E-02,0.014,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.486615924537224,0.1400490004998253,3S9D,3S9D_KA105A,A,K105A
3S9D_A_B,RA144A,RA115A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.2E-07,1.2e-07,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),360000.0,360000.0,3700000.0,3700000.0,4.3E-02,0.043,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-9.44118097464145,2.1854839503956,3S9D,3S9D_RA115A,A,R115A
3S9D_A_B,AA145G,AA116G,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-07,1e-07,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),2900000.0,2900000.0,3700000.0,3700000.0,2.88E-01,0.288,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-9.54919774264398,2.07746718239307,3S9D,3S9D_AA116G,A,A116G
3S9D_A_B,AA145M,AA116M,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.79E-08,1.79e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4400000.0,4400000.0,3700000.0,3700000.0,7.9E-02,0.079,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.568434049785422,1.0582308752516276,3S9D,3S9D_AA116M,A,A116M
3S9D_A_B,MA148A,MA119A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.43E-07,1.43e-07,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-9.33729280859932,2.2893721164377308,3S9D,3S9D_MA119A,A,M119A
3S9D_A_B,RA149A,RA120A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5.38E-07,5.38e-07,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-8.552285677335735,3.074379247701314,3S9D,3S9D_RA120A,A,R120A
3S9D_A_B,SA152A,SA123A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.38E-08,1.38e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3600000.0,3600000.0,3700000.0,3700000.0,4.9E-02,0.049,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.722549840720864,0.9041150843161851,3S9D,3S9D_SA123A,A,S123A
3S9D_A_B,LA153A,LA124A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.86E-08,2.86e-08,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3700000.0,3700000.0,3700000.0,3700000.0,1.05E-01,0.105,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-10.290807492539514,1.3358574324975354,3S9D,3S9D_LA124A,A,L124A
3S9D_A_B,NA156A,NA127A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.6E-09,2.6e-09,3E-09,3e-09,10984492,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3700000.0,3700000.0,3700000.0,3700000.0,1E-02,0.01,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.711445303727924,-0.0847803786908745,3S9D,3S9D_NA127A,A,N127A
3S9D_A_B,QA62A,QA48A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3000000.0,3000000.0,3666667.0,3666667.0,9E-03,0.009,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_QA48A,A,Q48A
3S9D_A_B,FA64A,FA50A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3250000.0,3250000.0,3666667.0,3666667.0,1.3E-02,0.013,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_FA50A,A,F50A
3S9D_A_B,NA65A,NA51A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4000000.0,4000000.0,3666667.0,3666667.0,1.2E-02,0.012,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_NA51A,A,N51A
3S9D_A_B,SA68A,SA54A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3333333.0,3333333.0,3666667.0,3666667.0,1E-02,0.01,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_SA54A,A,S54A
3S9D_A_B,TA69A,TA55A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4000000.0,4000000.0,3666667.0,3666667.0,1.2E-02,0.012,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_TA55A,A,T55A
3S9D_A_B,KA70A,KA56A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3333333.0,3333333.0,3666667.0,3666667.0,1E-02,0.01,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_KA56A,A,K56A
3S9D_A_B,SA73A,SA59A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3500000.0,3500000.0,3666667.0,3666667.0,1.4E-02,0.014,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_SA59A,A,S59A
3S9D_A_B,TA79A,TA65A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3250000.0,3250000.0,3666667.0,3666667.0,1.3E-02,0.013,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_TA65A,A,T65A
3S9D_A_B,LA80A,LA66A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-09,5e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3800000.0,3800000.0,3666667.0,3666667.0,1.9E-02,0.019,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.32402527088778,0.3026396541492708,3S9D,3S9D_LA66A,A,L66A
3S9D_A_B,KA83A,KA69A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3666667.0,3666667.0,3666667.0,3666667.0,1.1E-02,0.011,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_KA69A,A,K69A
3S9D_A_B,YA85A,YA71A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-09,5e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3800000.0,3800000.0,3666667.0,3666667.0,1.9E-02,0.019,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.32402527088778,0.3026396541492708,3S9D,3S9D_YA71A,A,Y71A
3S9D_A_B,TA86A,TA72A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4000000.0,4000000.0,3666667.0,3666667.0,1.6E-02,0.016,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_TA72A,A,T72A
3S9D_A_B,YA89A,YA75A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-09,5e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3400000.0,3400000.0,3666667.0,3666667.0,1.7E-02,0.017,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.32402527088778,0.3026396541492708,3S9D,3S9D_YA75A,A,Y75A
3S9D_A_B,QA90A,QA76A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3250000.0,3250000.0,3666667.0,3666667.0,1.3E-02,0.013,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_QA76A,A,Q76A
3S9D_A_B,NA93A,NA79A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),4000000.0,4000000.0,3666667.0,3666667.0,1.6E-02,0.016,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_NA79A,A,N79A
3S9D_A_B,EA96A,EA82A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,16171819,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),3250000.0,3250000.0,3666667.0,3666667.0,1.3E-02,0.013,1.1E-02,0.011,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, like this mutations, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_EA82A,A,E82A
3S9D_A_B,RA12A,RA5A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.57E-09,8.57e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.004794475022385,0.6218704500146668,3S9D,3S9D_RA5A,A,R5A
3S9D_A_B,LA15A,LA8A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-08,3e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.262493818945051,1.3641711060919963,3S9D,3S9D_LA8A,A,L8A
3S9D_A_B,MA16A,MA9A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_MA9A,A,M9A
3S9D_A_B,AA19W,AA12W,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.21E-09,2.21e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.807729965905418,-0.1810650408683685,3S9D,3S9D_AA12W,A,A12W
3S9D_A_B,RA22A,RA15A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.35E-09,4.35e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.40653135894031,0.2201335660967398,3S9D,3S9D_RA15A,A,R15A
3S9D_A_B,RA23A,RA16A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.53E-09,3.53e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.53028152908985,0.0963833959471998,3S9D,3S9D_RA16A,A,R16A
3S9D_A_B,IA24A,IA17A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.61E-09,2.61e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.70917101308958,-0.082506088052531,3S9D,3S9D_IA17A,A,I17A
3S9D_A_B,SA25A,SA18A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_SA18A,A,S18A
3S9D_A_B,LA26A,LA19A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.36E-08,1.36e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.73119892839826,0.8954659966387908,3S9D,3S9D_LA19A,A,L19A
3S9D_A_B,FA27A,FA20A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-08,1e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.913368848735976,0.7132960763010736,3S9D,3S9D_FA20A,A,F20A
3S9D_A_B,LA30A,LA23A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.31E-06,2.31e-06,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-7.688997679754215,3.9376672452828334,3S9D,3S9D_LA23A,A,L23A
3S9D_A_B,LA30V,LA23V,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.3E-07,1.3e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.393759513695732,2.232905411341317,3S9D,3S9D_LA23V,A,L23V
3S9D_A_B,KA31A,KA24A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-08,1e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.913368848735976,0.7132960763010736,3S9D,3S9D_KA24A,A,K24A
3S9D_A_B,DA32A,DA25A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.43E-08,1.43e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.701463914691317,0.9252010103457344,3S9D,3S9D_DA25A,A,D25A
3S9D_A_B,RA33A,RA26A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.2E-04,0.00012,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-5.348667656365457,6.277997268671593,3S9D,3S9D_RA26A,A,R26A
3S9D_A_B,RA33K,RA26K,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6E-06,6e-06,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-7.123495184609257,4.503169740427793,3S9D,3S9D_RA26K,A,R26K
3S9D_A_B,HA34A,HA27A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.82E-09,8.82e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.987759029273464,0.6389058957635854,3S9D,3S9D_HA27A,A,H27A
3S9D_A_B,DA35A,DA28A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6E-09,6e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.216008502885249,0.410656422151801,3S9D,3S9D_DA28A,A,D28A
3S9D_A_B,RA120K,RA91K,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.16E-09,3.16e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.595881274632545,0.0307836504045067,3S9D,3S9D_RA91K,A,R91K
3S9D_A_B,KA121A,KA92A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.63E-09,2.63e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.704648456901008,-0.0779835318639587,3S9D,3S9D_KA92A,A,K92A
3S9D_A_B,RA125A,RA96A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.84E-09,4.84e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.343293700331545,0.2833712247055064,3S9D,3S9D_RA96A,A,R96A
3S9D_A_B,KA131A,KA102A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_KA102A,A,K102A
3S9D_A_B,EA132A,EA103A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.27E-09,2.27e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.79185976742348,-0.1651948423864304,3S9D,3S9D_EA103A,A,E103A
3S9D_A_B,KA133A,KA104A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.29E-09,4.29e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.414759990992389,0.2119049340446608,3S9D,3S9D_KA104A,A,K104A
3S9D_A_B,KA134A,KA105A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.17E-09,4.17e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.431568266786895,0.1950966582501543,3S9D,3S9D_KA105A,A,K105A
3S9D_A_B,RA144A,RA115A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-07,1e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.54919774264398,2.07746718239307,3S9D,3S9D_RA115A,A,R115A
3S9D_A_B,AA145M,AA116M,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.88E-08,1.88e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.53937063226214,1.08729429277491,3S9D,3S9D_AA116M,A,A116M
3S9D_A_B,AA145G,AA116G,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-07,1e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.54919774264398,2.07746718239307,3S9D,3S9D_AA116G,A,A116G
3S9D_A_B,MA148A,MA119A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1E-07,1e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.54919774264398,2.07746718239307,3S9D,3S9D_MA119A,A,M119A
3S9D_A_B,RA149A,RA120A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-07,3e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-8.898322712853057,2.7283422121839926,3S9D,3S9D_RA120A,A,R120A
3S9D_A_B,SA152A,SA123A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-08,3e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.262493818945051,1.3641711060919963,3S9D,3S9D_SA123A,A,S123A
3S9D_A_B,LA153A,LA124A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-08,3e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.262493818945051,1.3641711060919963,3S9D,3S9D_LA124A,A,L124A
3S9D_A_B,NA156A,NA127A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_NA127A,A,N127A
3S9D_A_B,EB28R,EB17R,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_EB17R,B,E17R
3S9D_A_B,YB43A,YB32A,INT,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.73E-08,2.73e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.318368368086372,1.308296556950676,3S9D,3S9D_YB32A,B,Y32A
3S9D_A_B,TB44A,TB33A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5E-08,5e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.959854164795782,1.6668107602412672,3S9D,3S9D_TB33A,B,T33A
3S9D_A_B,IB45A,IB34A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6E-08,6e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.85183739679325,1.774827528243799,3S9D,3S9D_IB34A,B,I34A
3S9D_A_B,MB46A,MB35A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.5E-07,1.5e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.308979135004858,2.317685790032192,3S9D,3S9D_MB35A,B,M35A
3S9D_A_B,MB46V,MB35V,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6.52E-08,6.52e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.802595805433612,1.824069119603436,3S9D,3S9D_MB35V,B,M35V
3S9D_A_B,SB47A,SB36A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",7.5E-09,7.5e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.08380666324866,0.5428582617883908,3S9D,3S9D_SB36A,B,S36A
3S9D_A_B,KB48A,KB37A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9.68E-09,9.68e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.93263727817974,0.6940276468573092,3S9D,3S9D_KB37A,B,K37A
3S9D_A_B,EB50A,EB39A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.29E-09,4.29e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.414759990992389,0.2119049340446608,3S9D,3S9D_EB39A,B,E39A
3S9D_A_B,DB51A,DB40A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_DB40A,B,D40A
3S9D_A_B,KB53A,KB42A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.11E-09,8.11e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.037479970678048,0.589184954359002,3S9D,3S9D_KB42A,B,K42A
3S9D_A_B,RB73A,RB62A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-09,4e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.456227110524368,0.170437814512681,3S9D,3S9D_RB62A,B,R62A
3S9D_A_B,SB74A,SB63A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.76E-09,4.76e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.353168128639632,0.2734967963974171,3S9D,3S9D_SB63A,B,S63A
3S9D_A_B,TB75A,TB64A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.62E-09,4.62e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.370854575878404,0.2558103491586454,3S9D,3S9D_TB64A,B,T64A
3S9D_A_B,HB76A,HB65A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",8.82E-09,8.82e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.987759029273464,0.6389058957635854,3S9D,3S9D_HB65A,B,H65A
3S9D_A_B,EB77A,EB66A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.76E-07,1.76e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.214276455032351,2.4123884700046965,3S9D,3S9D_EB66A,B,E66A
3S9D_A_B,AB78M,AB67M,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.26E-09,2.26e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.794475453719754,-0.167810528682704,3S9D,3S9D_AB67M,B,A67M
3S9D_A_B,VB80A,VB69A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.5E-07,1.5e-07,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-9.308979135004858,2.317685790032192,3S9D,3S9D_VB69A,B,V69A
3S9D_A_B,HB97A,HB84A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.23E-09,3.23e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.58290058671472,0.0437643383223296,3S9D,3S9D_HB84A,B,H84A
3S9D_A_B,NB98A,NB85A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.4E-09,2.4e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.75886676467364,-0.1322018396365916,3S9D,3S9D_NB85A,B,N85A
3S9D_A_B,WB100A,WB87A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.76E-08,1.76e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.57844756112435,1.0482173639127002,3S9D,3S9D_WB87A,B,W87A
3S9D_A_B,IB103A,IB90A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.75E-08,3.75e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.130291979308462,1.496372945728588,3S9D,3S9D_IB90A,B,I90A
3S9D_A_B,DB104A,DB91A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.76E-08,1.76e-08,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-10.57844756112435,1.0482173639127002,3S9D,3S9D_DB91A,B,D91A
3S9D_A_B,DB138R,DB121R,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",2.54E-09,2.54e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.725277495843216,-0.0986125708061678,3S9D,3S9D_DB121R,B,D121R
3S9D_A_B,HB187A,HB166A,RIM,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3E-09,3e-09,3E-09,3e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.62666492503705,-11.62666492503705,0.0,3S9D,3S9D_HB166A,B,H166A
3S9D_A_B,RA149A,RA120A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5.84E-07,5.84e-07,3.11E-09,3.11e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.60533046989091,-8.50367948127554,3.1016509886153703,3S9D,3S9D_RA120A,A,R120A
3S9D_A_B,EB77A,EB66A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.79E-07,1.79e-07,3.11E-09,3.11e-09,21854986,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SPR,2,-11.60533046989091,-9.204262943693424,2.4010675261974868,3S9D,3S9D_EB66A,B,E66A
3S9D_A_B,IB103A,IB90A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-08,4e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.09205600443237,1.642625688607211,3S9D,3S9D_IB90A,B,I90A
3S9D_A_B,TB44A,TB33A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",7.4E-08,7.4e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.727588052180325,2.0070936408592583,3S9D,3S9D_TB33A,B,T33A
3S9D_A_B,IB45A,IB34A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6.5E-08,6.5e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.804415935847535,1.9302657571920463,3S9D,3S9D_IB34A,B,I34A
3S9D_A_B,MB46V,MB35V,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.49E-07,3.49e-07,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-8.808690979534214,2.9259907135053678,3S9D,3S9D_MB35V,B,M35V
3S9D_A_B,HB76A,HB65A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.9E-08,1.9e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.533101240597029,1.2015804524425544,3S9D,3S9D_HB65A,B,H65A
3S9D_A_B,EB77A,EB66A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.52E-07,1.52e-07,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.301131974141622,2.433549718897959,3S9D,3S9D_EB66A,B,E66A
3S9D_A_B,WB100A,WB87A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.4E-08,3.4e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.188340666609866,1.5463410264297153,3S9D,3S9D_WB87A,B,W87A
3S9D_A_B,IB103A,IB90A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4.5E-08,4.5e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.022275211305931,1.7124064817336482,3S9D,3S9D_IB90A,B,I90A
3S9D_A_B,DB104A,DB91A,SUR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.9E-08,3.9e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.107055589996806,1.6276261030427754,3S9D,3S9D_DB91A,B,D91A
3S9D_A_B,LA15A,LA8A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",6.9E-08,6.9e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.769035156780667,1.9656465362589124,3S9D,3S9D_LA8A,A,L8A
3S9D_A_B,LA26A,LA19A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",3.1E-08,3.1e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.24306742336684,1.4916142696727412,3S9D,3S9D_LA19A,A,L19A
3S9D_A_B,LA30A,LA23A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.7E-06,1.7e-06,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-7.870654876577675,3.864026816461906,3S9D,3S9D_LA23A,A,L23A
3S9D_A_B,RA144A,RA115A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9.9E-08,9.9e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.555152084057717,2.1795296089818663,3S9D,3S9D_RA115A,A,R115A
3S9D_A_B,AA145G,AA116G,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",9.6E-08,9.6e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.57338281427804,2.161298878761542,3S9D,3S9D_AA116G,A,A116G
3S9D_A_B,MA148A,MA119A,SUP,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.43E-07,1.43e-07,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-9.33729280859932,2.3973888844402627,3S9D,3S9D_MA119A,A,M119A
3S9D_A_B,RA149A,RA120A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",5.4E-07,5.4e-07,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-8.550087337211405,3.1845943558281764,3S9D,3S9D_RA120A,A,R120A
3S9D_A_B,SA152A,SA123A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",1.6E-08,1.6e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.634914266220765,1.099767426818817,3S9D,3S9D_SA123A,A,S123A
3S9D_A_B,LA153A,LA124A,COR,,"3S9D_A_B,3SE3_B_C,3SE4_B_C",4E-08,4e-08,2.5E-09,2.5e-09,11698684,Interferon alpha-2,Interferon alpha/beta receptor 2,298(assumed),,,,,,,,,,,,,"The crystal structure contains the HEQ IFNa2 varient, and the ddG and kinetic data is for the wild-type. However, the three mutations in the HEQ varient are on the opposite side of IFN2a from the IFNAR2 binding site, and have no affect on the kinetics or affinity of the interactions [17310065,16479007].",SP,2,-11.73468169303958,-10.09205600443237,1.642625688607211,3S9D,3S9D_LA124A,A,L124A
1E50_A_B,DA66A,DA8A,RIM,,"1E50_A_B,1H9D_A_B",7.1E-09,7.1e-09,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-11.116277911685826,-0.4022527070120816,1E50,1E50_DA8A,A,D8A
1E50_A_B,NA69A,NA11A,SUP,,"1E50_A_B,1H9D_A_B",4.4E-08,4.4e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-10.03558929933596,0.6784359053377855,1E50,1E50_NA11A,A,N11A
1E50_A_B,MA106A,MA48A,COR,,"1E50_A_B,1H9D_A_B",1.3E-07,1.3e-07,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-9.393759513695732,1.3202656909780115,1E50,1E50_MA48A,A,M48A
1E50_A_B,NA109A,NA51A,SUP,,"1E50_A_B,1H9D_A_B",8.5E-07,8.5e-07,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-8.281311298729477,2.432713905944267,1E50,1E50_NA51A,A,N51A
1E50_A_B,YA113A,YA55A,COR,,"1E50_A_B,1H9D_A_B",6.9E-08,6.9e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-9.769035156780667,0.9449900478930752,1E50,1E50_YA55A,A,Y55A
1E50_A_B,SA114A,SA56A,COR,,"1E50_A_B,1H9D_A_B",7.3E-08,7.3e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-9.735648747730949,0.9783764569427972,1E50,1E50_SA56A,A,S56A
1E50_A_B,TA149A,TA91A,COR,,"1E50_A_B,1H9D_A_B",1.8E-07,1.8e-07,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-9.200962367002328,1.5130628376714164,1E50,1E50_TA91A,A,T91A
1E50_A_B,VA159A,VA101A,COR,,"1E50_A_B,1H9D_A_B",1.3E-08,1.3e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-10.757930619787729,-0.0439054151139846,1E50,1E50_VA101A,A,V101A
1E50_A_B,TA161A,TA103A,COR,,"1E50_A_B,1H9D_A_B",5.6E-07,5.6e-07,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-8.528541254278142,2.185483950395602,1E50,1E50_TA103A,A,T103A
1E50_A_B,RB33A,RB32A,RIM,,"1E50_A_B,1H9D_A_B",2.8E-07,2.8e-07,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-8.939197676429945,1.774827528243799,1E50,1E50_RB32A,B,R32A
1E50_A_B,VB58A,VB57A,COR,,"1E50_A_B,1H9D_A_B",1.4E-08,1.4e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-10.714025204673744,0.0,1E50,1E50_VB57A,B,V57A
1E50_A_B,NB63A,NB62A,COR,,"1E50_A_B,1H9D_A_B",6.5E-08,6.5e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-9.804415935847535,0.909609268826209,1E50,1E50_NB62A,B,N62A
1E50_A_B,SB65A,SB64A,COR,,"1E50_A_B,1H9D_A_B",1.7E-08,1.7e-08,1.4E-08,1.4e-08,12807883,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.714025204673744,-10.598997088761667,0.1150281159120751,1E50,1E50_SB64A,B,S64A
1E50_A_B,DA66A,DA8A,RIM,,"1E50_A_B,1H9D_A_B",1.77E-08,1.77e-08,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-10.575090883681948,-0.2300909766843624,1E50,1E50_DA8A,A,D8A
1E50_A_B,NA109A,NA51A,SUP,,"1E50_A_B,1H9D_A_B",2.81E-07,2.81e-07,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-8.937085545908598,1.4079143610889862,1E50,1E50_NA51A,A,N51A
1E50_A_B,YA113A,YA55A,COR,,"1E50_A_B,1H9D_A_B",1.16E-07,1.16e-07,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-9.461266016183828,0.8837338908137564,1E50,1E50_YA55A,A,Y55A
1E50_A_B,RA142A,RA84A,SUR,,"1E50_A_B,1H9D_A_B",1.89E-08,1.89e-08,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-10.536227643544771,-0.191227736547189,1E50,1E50_RA84A,A,R84A
1E50_A_B,KA144M,KA86M,INT,,"1E50_A_B,1H9D_A_B",4.48E-08,4.48e-08,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-10.024914200006728,0.3200857069908558,1E50,1E50_KA86M,A,K86M
1E50_A_B,TA149A,TA91A,COR,,"1E50_A_B,1H9D_A_B",1.52E-07,1.52e-07,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-9.301131974141622,1.043867932855962,1E50,1E50_TA91A,A,T91A
1E50_A_B,NB63A,NB62A,COR,,"1E50_A_B,1H9D_A_B",1.46E-07,1.46e-07,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-9.324992325579146,1.0200075814184384,1E50,1E50_NB62A,B,N62A
1E50_A_B,NB104A,NB99A,COR,,"1E50_A_B,1H9D_A_B",2.81E-07,2.81e-07,2.61E-08,2.61e-08,11257229,AML1 Runx1 Runt domain,Core-binding factor beta,298(assumed),,,,,,,,,,,,,,ESMA,2,-10.344999906997584,-8.937085545908598,1.4079143610889862,1E50,1E50_NB99A,B,N99A
3F1S_A_B,MA71A,MA33A,COR,,3F1S_A_B,1.7E-08,1.7e-08,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-10.598997088761667,1.2389806143649515,3F1S,3F1S_MA33A,A,M33A
3F1S_A_B,DA74A,DA36A,RIM,,3F1S_A_B,8.4E-08,8.4e-08,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-9.65249375273102,2.185483950395602,3F1S,3F1S_DA36A,A,D36A
3F1S_A_B,DA238A,DA200A,COR,,3F1S_A_B,4.2E-09,4.2e-09,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-11.427321280974818,0.4106564221518027,3F1S,3F1S_DA200A,A,D200A
3F1S_A_B,KA239A,KA201A,COR,,3F1S_A_B,1E-10,1e-10,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-13.641711060919972,-1.803733357793352,3F1S,3F1S_KA201A,A,K201A
3F1S_A_B,KA239C,KA201C,COR,,3F1S_A_B,1E-10,1e-10,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-13.641711060919972,-1.803733357793352,3F1S,3F1S_KA201C,A,K201C
3F1S_A_B,YA240A,YA202A,COR,,3F1S_A_B,3.3E-07,3.3e-07,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-8.841856007756641,2.996121695369979,3F1S,3F1S_YA202A,A,Y202A
3F1S_A_B,DA293A,DA255A,COR,,3F1S_A_B,1.2E-06,1.2e-06,2.1E-09,2.1e-09,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,,IAFL,2,-11.83797770312662,-8.077009868549451,3.760967834577169,3F1S,3F1S_DA255A,A,D255A
3F1S_A_B,DA238A,DA200A,COR,,3F1S_A_B,5.2E-08,5.2e-08,1.6E-08,1.6e-08,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,High salt,IAFL,2,-10.634914266220765,-9.936617775484123,0.6982964907366398,3F1S,3F1S_DA200A,A,D200A
3F1S_A_B,KA239A,KA201A,COR,,3F1S_A_B,3E-10,3e-10,1.6E-08,1.6e-08,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,High salt,IAFL,2,-10.634914266220765,-12.990836031129048,-2.355921764908283,3F1S,3F1S_KA201A,A,K201A
3F1S_A_B,KA239C,KA201C,COR,,3F1S_A_B,1.1E-09,1.1e-09,1.6E-08,1.6e-08,25713144,Z-dependent protease inhibitor,Protein A/Z,298,,,,,,,,,,,,,High salt,IAFL,2,-10.634914266220765,-12.22107324973156,-1.5861589835107957,3F1S,3F1S_KA201C,A,K201C
4GNK_A_B,KA311A,KA294A,SUR,,4GNK_A_B,2.6E-07,2.6e-07,2.2E-07,2.2e-07,23377541,G(q) alpha,PLC beta 3,298(assumed),,,,,,,,,,,,,,FL,2,-9.082074615395763,-8.98310309154393,0.0989715238518336,4GNK,4GNK_KA294A,A,K294A
4GNK_A_B,LB876A,LB764A,SUR,,4GNK_A_B,2E-08,2e-08,2.2E-07,2.2e-07,23377541,G(q) alpha,PLC beta 3,298(assumed),,,,,,,,,,,,,,FL,2,-9.082074615395763,-10.502712426584177,-1.4206378111884117,4GNK,4GNK_LB764A,B,L764A
4GNK_A_B,TB652E,TB540E,SUR,,4GNK_A_B,1.6E-07,1.6e-07,2.2E-07,2.2e-07,23377541,G(q) alpha,PLC beta 3,298(assumed),,,,,,,,,,,,,,FL,2,-9.082074615395763,-9.270743160128768,-0.1886685447330034,4GNK,4GNK_TB540E,B,T540E
4HSA_AB_C,RA55V,RA28V,SUR,,4HSA_AB_C,6.56E-09,6.56e-09,2.46E-09,2.46e-09,23695682,Interleukin-17a,Interleukin-17 receptor A,298(assumed),118000.0,118000.0,246000.0,246000.0,7.73E-04,0.000773,3.2E-04,0.00032,,,,,,SPR,2,-11.744237577360565,-11.16314334069608,0.5810942366644838,4HSA,4HSA_RA28V,A,R28V
4HSA_AB_C,WA67V,WA40V,SUR,,4HSA_AB_C,1.69E-09,1.69e-09,2.46E-09,2.46e-09,23695682,Interleukin-17a,Interleukin-17 receptor A,298(assumed),291000.0,291000.0,246000.0,246000.0,4.9E-04,0.00049,3.2E-04,0.00032,,,,,,SPR,2,-11.744237577360565,-11.966663496931478,-0.222425919570913,4HSA,4HSA_WA40V,A,W40V
4HSA_AB_C,YA85I,YA58I,RIM,,4HSA_AB_C,3E-09,3e-09,2.46E-09,2.46e-09,23695682,Interleukin-17a,Interleukin-17 receptor A,298(assumed),121000.0,121000.0,246000.0,246000.0,3.62E-04,0.000362,3.2E-04,0.00032,,,,,,SPR,2,-11.744237577360565,-11.62666492503705,0.1175726523235152,4HSA,4HSA_YA58I,A,Y58I
4HSA_AB_C,HA86S,HA59S,COR,,4HSA_AB_C,2E-09,2e-09,2.46E-09,2.46e-09,23695682,Interleukin-17a,Interleukin-17 receptor A,298(assumed),199000.0,199000.0,246000.0,246000.0,3.96E-04,0.000396,3.2E-04,0.00032,,,,,,SPR,2,-11.744237577360565,-11.866883532676171,-0.1226459553156082,4HSA,4HSA_HA59S,A,H59S
4KRP_A_B,EB113A,EB105A,RIM,AB/AG,AB/AG,>2.5E-06,2.5e-06,1.66E-07,1.66e-07,23791944,Epidermal growth factor receptor,Nanobody 9G8,298,,,,,,,,,,,,,,SPR,2,-9.248932648722583,-7.64216837476359,1.6067642739589931,4KRP,4KRP_EB105A,B,E105A
4O27_A_B,YA223A,YA215A,COR,,"4O27_A_B,4NZW_A_B,4FZA_A_B",1.88E-07,1.88e-07,2.5E-08,2.5e-08,24746913,MO25,MST3,298(assumed),,,,,,,,,,,,,,BI,2,-10.370510586947583,-9.175199526170143,1.195311060777442,4O27,4O27_YA215A,A,Y215A
4O27_A_B,KA96A,KA88A,COR,,"4O27_A_B,4NZW_A_B,4FZA_A_B",1.41E-07,1.41e-07,2.5E-08,2.5e-08,24746913,MO25,MST3,298(assumed),,,,,,,,,,,,,,BI,2,-10.370510586947583,-9.345637340682824,1.024873246264761,4O27,4O27_KA88A,A,K88A
4O27_A_B,EB58A,EB42A,COR,,"4O27_A_B,4NZW_A_B,4FZA_A_B",4.68E-08,4.68e-08,2.5E-08,2.5e-08,24746913,MO25,MST3,298(assumed),,,,,,,,,,,,,,BI,2,-10.370510586947583,-9.999038821994274,0.371471764953311,4O27,4O27_EB42A,B,E42A
4O27_A_B,EB138A,EB122A,RIM,,"4O27_A_B,4NZW_A_B,4FZA_A_B",4.16E-08,4.16e-08,2.5E-08,2.5e-08,24746913,MO25,MST3,298(assumed),,,,,,,,,,,,,,BI,2,-10.370510586947583,-10.068819615120717,0.3016909718268703,4O27,4O27_EB122A,B,E122A
4P5T_CD_AB,KC39A,KC40A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.1E-05,4.1e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.984913498843304,1.1385816857659528,4P5T,4P5T_KC40A,C,K40A
4P5T_CD_AB,DC55A,DC56A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.7E-05,1.7e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.506483770485678,0.6170114141235787,4P5T,4P5T_DC56A,C,D56A
4P5T_CD_AB,QC57A,QC58A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_QC58A,C,Q58A
4P5T_CD_AB,LC60A,LC61A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.3E-05,3.3e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.113513795572649,1.009981389036608,4P5T,4P5T_LC61A,C,L61A
4P5T_CD_AB,QC61A,QC62A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_QC62A,C,Q62A
4P5T_CD_AB,NC62A,NC63A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7.5E-05,7.5e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.62712223888067,1.496372945728587,4P5T,4P5T_NC63A,C,N63A
4P5T_CD_AB,VC65A,VC66A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",2.6E-05,2.6e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.254760879359936,0.8687343052493208,4P5T,4P5T_VC66A,C,V66A
4P5T_CD_AB,KC67A,KC68A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.2E-05,3.2e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.13174452579297,0.9917506588162864,4P5T,4P5T_KC68A,C,K68A
4P5T_CD_AB,HC68A,HC69A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.3E-05,3.3e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.113513795572649,1.009981389036608,4P5T,4P5T_HC69A,C,H69A
4P5T_CD_AB,VC72A,VC73A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_VC73A,C,V73A
4P5T_CD_AB,KC75A,KC76A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.1E-05,1.1e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.764388825363572,0.3591063592456853,4P5T,4P5T_KC76A,C,K76A
4P5T_CD_AB,FD-25A,FD1A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_FD1A,D,F1A
4P5T_CD_AB,ED-24A,ED2A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.6E-05,3.6e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.061963732666531,1.0615314519427257,4P5T,4P5T_ED2A,D,E2A
4P5T_CD_AB,QD-22A,QD4A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9.8E-05,9.8e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.468653558395324,1.6548416262139325,4P5T,4P5T_QD4A,D,Q4A
4P5T_CD_AB,KD-21A,KD5A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.73E-04,0.000173,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.13194880856189,1.991546376047367,4P5T,4P5T_KD5A,D,K5A
4P5T_CD_AB,KD-19A,KD7A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8.2E-05,8.2e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.574257076691502,1.5492381079177546,4P5T,4P5T_KD7A,D,K7A
4P5T_CD_AB,ND-17A,ND9A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_ND9A,D,N9A
4P5T_CD_AB,KD-16A,KD10A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9E-06,9e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.883276576970135,0.2402186076391217,4P5T,4P5T_KD10A,D,K10A
4P5T_CD_AB,VD-14A,VD12A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P5T,4P5T_VD12A,D,V12A
4P5T_CD_AB,DD-13A,DD13A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_DD13A,D,D13A
4P5T_CD_AB,ED59A,ED67A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9E-06,9e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.883276576970135,0.2402186076391217,4P5T,4P5T_ED67A,D,E67A
4P5T_CD_AB,YD60A,YD68A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P5T,4P5T_YD68A,D,Y68A
4P5T_CD_AB,SD63A,SD71A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_SD71A,D,S71A
4P5T_CD_AB,QD64A,QD72A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_QD72A,D,Q72A
4P5T_CD_AB,PD65A,PD73A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_PD73A,D,P73A
4P5T_CD_AB,ED66A,ED74A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.7E-05,1.7e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.506483770485678,0.6170114141235787,4P5T,4P5T_ED74A,D,E74A
4P5T_CD_AB,ID67A,ID75A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P5T,4P5T_ID75A,D,I75A
4P5T_CD_AB,ED69A,ED77A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.3E-05,3.3e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.113513795572649,1.009981389036608,4P5T,4P5T_ED77A,D,E77A
4P5T_CD_AB,RD70A,RD78A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.99E-04,0.000199,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.048997692563162,2.0744974920460946,4P5T,4P5T_RD78A,D,R78A
4P5T_CD_AB,RD72A,RD80A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_RD80A,D,R80A
4P5T_CD_AB,DD76A,DD84A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_DD84A,D,D84A
4P5T_CD_AB,TD77A,TD85A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",2.4E-05,2.4e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.302182340305652,0.8213128443036046,4P5T,4P5T_TD85A,D,T85A
4P5T_CD_AB,RD80A,RD88A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_RD88A,D,R88A
4P5T_CD_AB,HD81A,HD89A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",2.3E-05,2.3e-05,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.327396868295601,0.7960983163136559,4P5T,4P5T_HD89A,D,H89A
4P5T_CD_AB,ED84A,ED92A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,24813203,H2-A plus 3K peptide,14.C6 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P5T,4P5T_ED92A,D,E92A
4P23_CD_AB,KC39A,KC40A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.5E-05,4.5e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.929761893029941,1.1937332915793162,4P23,4P23_KC40A,C,K40A
4P23_CD_AB,DC55A,DC56A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.2E-05,3.2e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.13174452579297,0.9917506588162864,4P23,4P23_DC56A,C,D56A
4P23_CD_AB,QC57A,QC58A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.1E-05,3.1e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.1505541050908485,0.9729410795184084,4P23,4P23_QC58A,C,Q58A
4P23_CD_AB,LC60A,LC61A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3E-05,3e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.169980500669062,0.9535146839401952,4P23,4P23_LC61A,C,L61A
4P23_CD_AB,QC61A,QC62A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.51E-04,0.000151,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.212529244214097,1.91096594039516,4P23,4P23_QC62A,C,Q62A
4P23_CD_AB,NC62A,NC63A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7.7E-05,7.7e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.611530497361144,1.5119646872481125,4P23,4P23_NC63A,C,N63A
4P23_CD_AB,VC65A,VC66A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.3E-05,4.3e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.956696166737592,1.1667990178716652,4P23,4P23_VC66A,C,V66A
4P23_CD_AB,KC67A,KC68A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.9E-05,1.9e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.440587922321038,0.6829072622882189,4P23,4P23_KC68A,C,K68A
4P23_CD_AB,HC68A,HC69A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.7E-05,1.7e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.506483770485678,0.6170114141235787,4P23,4P23_HC69A,C,H69A
4P23_CD_AB,VC72A,VC73A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_VC73A,C,V73A
4P23_CD_AB,KC75A,KC76A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_KC76A,C,K76A
4P23_CD_AB,FD-25A,FD1A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_FD1A,D,F1A
4P23_CD_AB,ED-24A,ED2A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.3E-05,4.3e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.956696166737592,1.1667990178716652,4P23,4P23_ED2A,D,E2A
4P23_CD_AB,QD-22A,QD4A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.9E-05,1.9e-05,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.440587922321038,0.6829072622882189,4P23,4P23_QD4A,D,Q4A
4P23_CD_AB,KD-21A,KD5A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",2.59E-04,0.000259,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-4.892872828053705,2.230622356555552,4P23,4P23_KD5A,D,K5A
4P23_CD_AB,KD-19A,KD7A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.58E-04,0.000458,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-4.5551508342614335,2.5683443503478234,4P23,4P23_KD7A,D,K7A
4P23_CD_AB,ND-17A,ND9A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_ND9A,D,N9A
4P23_CD_AB,KD-16A,KD10A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_KD10A,D,K10A
4P23_CD_AB,VD-14A,VD12A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_VD12A,D,V12A
4P23_CD_AB,DD-13A,DD13A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_DD13A,D,D13A
4P23_CD_AB,ED59A,ED68A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_ED68A,D,E68A
4P23_CD_AB,YD60A,YD69A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9E-06,9e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.883276576970135,0.2402186076391217,4P23,4P23_YD69A,D,Y69A
4P23_CD_AB,SD63A,SD72A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_SD72A,D,S72A
4P23_CD_AB,QD64A,QD73A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_QD73A,D,Q73A
4P23_CD_AB,PD65A,PD74A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_PD74A,D,P74A
4P23_CD_AB,ED66A,ED75A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_ED75A,D,E75A
4P23_CD_AB,ID67A,ID76A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_ID76A,D,I76A
4P23_CD_AB,ED69A,ED78A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_ED78A,D,E78A
4P23_CD_AB,RD70A,RD79A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.98E-04,0.000198,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-5.051982343629923,2.071512840979333,4P23,4P23_RD79A,D,R79A
4P23_CD_AB,RD72A,RD81A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_RD81A,D,R81A
4P23_CD_AB,DD76A,DD85A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_DD85A,D,D85A
4P23_CD_AB,TD77A,TD86A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-06,6e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.123495184609257,0.0,4P23,4P23_TD86A,D,T86A
4P23_CD_AB,RD80A,RD89A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_RD89A,D,R89A
4P23_CD_AB,HD81A,HD90A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8E-06,8e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-6.953057370096575,0.1704378145126819,4P23,4P23_HD90A,D,H90A
4P23_CD_AB,ED84A,ED93A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7E-06,7e-06,6E-06,6e-06,22101158,H2-A plus 3K peptide,J809.B5 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-7.123495184609257,-7.032168308549555,0.0913268760597016,4P23,4P23_ED93A,D,E93A
3C60_CD_AB,KC40A,KC40A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.77E-04,0.000177,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.118406459313957,1.5944323031434982,3C60,3C60_KC40A,C,K40A
3C60_CD_AB,DC56A,DC56A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.9E-05,3.9e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.014542271720815,0.6982964907366398,3C60,3C60_DC56A,C,D56A
3C60_CD_AB,QC58A,QC58A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6.1E-05,6.1e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.749531260786302,0.963307501671153,3C60,3C60_QC58A,C,Q58A
3C60_CD_AB,LC61A,LC61A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",5.9E-05,5.9e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.7692814891048805,0.9435572733525746,3C60,3C60_LC61A,C,L61A
3C60_CD_AB,QC62A,QC62A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",5.2E-05,5.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.844104457208133,0.8687343052493217,3C60,3C60_QC62A,C,Q62A
3C60_CD_AB,NC63A,NC63A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",6E-05,6e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.75932407851726,0.9535146839401952,3C60,3C60_NC63A,C,N63A
3C60_CD_AB,VC66A,VC66A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",9.9E-05,9.9e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.462638765781725,1.2501999966757298,3C60,3C60_VC66A,C,V66A
3C60_CD_AB,KC68A,KC68A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.1E-05,3.1e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.1505541050908485,0.5622846573666065,3C60,3C60_KC68A,C,K68A
3C60_CD_AB,HC69A,HC69A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",2.2E-05,2.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.35373240321177,0.3591063592456853,3C60,3C60_HC69A,C,H69A
3C60_CD_AB,VC73A,VC73A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_VC73A,C,V73A
3C60_CD_AB,KC76A,KC76A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_KC76A,C,K76A
3C60_CD_AB,FD1A,FD1A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_FD1A,D,F1A
3C60_CD_AB,ED2A,ED2A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_ED2A,D,E2A
3C60_CD_AB,QD4A,QD4A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8.6E-05,8.6e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.54603974458579,1.1667990178716652,3C60,3C60_QD4A,D,Q4A
3C60_CD_AB,KD5A,KD5A,SUP,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8.4E-05,8.4e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.559980434455027,1.152858328002428,3C60,3C60_KD5A,D,K5A
3C60_CD_AB,KD7A,KD7A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",4.53E-04,0.000453,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-4.561654214423173,2.1511845480342817,3C60,3C60_KD7A,D,K7A
3C60_CD_AB,ND9A,ND9A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_ND9A,D,N9A
3C60_CD_AB,KD10A,KD10A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_KD10A,D,K10A
3C60_CD_AB,VD12A,VD12A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_VD12A,D,V12A
3C60_CD_AB,DD13A,DD13A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_DD13A,D,D13A
3C60_CD_AB,ED85A,ED69A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_ED69A,D,E69A
3C60_CD_AB,YD86A,YD70A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_YD70A,D,Y70A
3C60_CD_AB,SD89A,SD73A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_SD73A,D,S73A
3C60_CD_AB,QD90A,QD74A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_QD74A,D,Q74A
3C60_CD_AB,PD91A,PD75A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_PD75A,D,P75A
3C60_CD_AB,ED92A,ED76A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_ED76A,D,E76A
3C60_CD_AB,ID93A,ID77A,INT,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_ID77A,D,I77A
3C60_CD_AB,ED95A,ED79A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_ED79A,D,E79A
3C60_CD_AB,RD96A,RD80A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",3.67E-04,0.000367,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-4.686383294924601,2.0264554675328537,3C60,3C60_RD80A,D,R80A
3C60_CD_AB,RD98A,RD82A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_RD82A,D,R82A
3C60_CD_AB,DD102A,DD86A,RIM,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_DD86A,D,D86A
3C60_CD_AB,TD103A,TD87A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",8.6E-05,8.6e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.54603974458579,1.1667990178716652,3C60,3C60_TD87A,D,T87A
3C60_CD_AB,RD106A,RD90A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.3E-05,1.3e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.665417301511738,0.047421460945717,3C60,3C60_RD90A,D,R90A
3C60_CD_AB,HD107A,HD91A,COR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",7.5E-05,7.5e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-5.62712223888067,1.0857165235767852,3C60,3C60_HD91A,D,H91A
3C60_CD_AB,ED110A,ED94A,SUR,TCR/pMHC,"TCR/pMHC,1JCK_A_B",1.2E-05,1.2e-05,1.2E-05,1.2e-05,22101158,H2-A plus 3K peptide,YAe62 TCR,298(assumed),,,,,,,,,,,,,,SPR,2,-6.712838762457455,-6.712838762457455,0.0,3C60,3C60_ED94A,D,E94A
4U6H_AB_E,NE27A,NE21A,COR,AB/AG,AB/AG,5E-11,5e-11,9E-11,9e-11,25031354,M12B9 fab,Vaccinia L1,298(assumed),559000.0,559000.0,512500.0,512500.0,6.4E-05,6.4e-05,4.8E-05,4.8e-05,,,,,,BI,2,-13.70413210743012,-14.052367483071771,-0.3482353756416518,4U6H,4U6H_NE21A,E,N21A
4U6H_AB_E,QE31A,QE25A,RIM,AB/AG,AB/AG,1.1E-10,1.1e-10,9E-11,9e-11,25031354,M12B9 fab,Vaccinia L1,298(assumed),490000.0,490000.0,512500.0,512500.0,1.1E-04,0.00011,4.8E-05,4.8e-05,,,,,,BI,2,-13.70413210743012,-13.585244355823557,0.1188877516065645,4U6H,4U6H_QE25A,E,Q25A
1FFW_A_B,AA103V,AA102V,SUP,,1FFW_A_B,1.23E-05,1.23e-05,1.23E-06,1.23e-06,7578071,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,-8.4,-12.0,-5.6,-13.0,,ITC,2,-8.062380681236375,-6.698209575144378,1.3641711060919972,1FFW,1FFW_AA102V,A,A102V
1FFW_A_B,YA51C,YA50C,INT,,1FFW_A_B,1.52E-06,1.52e-06,1.23E-06,1.23e-06,7578071,Chemotaxis protein CheY,Chemotaxis protein CheA,298,,,,,,,,,-13.6,-12.0,-18.9,-13.0,,ITC,2,-8.062380681236375,-7.936960868049625,0.1254198131867498,1FFW,1FFW_YA50C,A,Y50C
5UFE_A_B,GA12D,GA12D,SUR,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",6.4E-09,6.4e-09,5.03E-08,5.03e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,SP,2,-9.9563100745635,-11.177772528009156,-1.2214624534456586,5UFE,5UFE_GA12D,A,G12D
5UFE_A_B,GA12D,GA12D,SUR,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",4E-09,4e-09,4.1E-08,4.1e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,BI,2,-10.077426817119294,-11.456227110524368,-1.3788002934050745,5UFE,5UFE_GA12D,A,G12D
5UFE_A_B,GA12C,GA12C,SUR,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",2.1E-08,2.1e-08,4.1E-08,4.1e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,BI,2,-10.077426817119294,-10.473806597034622,-0.3963797799153283,5UFE,5UFE_GA12C,A,G12C
5UFE_A_B,GA12V,GA12V,SUR,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",1.2E-08,1.2e-08,4.1E-08,4.1e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,BI,2,-10.077426817119294,-10.805352080733446,-0.7279252636141518,5UFE,5UFE_GA12V,A,G12V
5UFE_A_B,QB27R,QB25R,RIM,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",8.24E-08,8.24e-08,5.03E-08,5.03e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,SP,2,-9.9563100745635,-9.663887411255365,0.2924226633081357,5UFE,5UFE_QB25R,B,Q25R
5UFE_A_B,GA12D,GA12D,SUR,,"5UFE_A_B,5UFQ_A_C,1K8R_A_B,1HE8_A_B",6.4E-09,6.4e-09,5.03E-08,5.03e-08,28724936,K-Ras,R11.1.6,298(assumed),,,,,,,,,,,,,,SP,2,-9.9563100745635,-11.177772528009156,-1.2214624534456586,5UFE,5UFE_GA12D,A,G12D
5TAR_A_B,FB15A,FB13A,INT,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",3.4E-06,3.4e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.459998454425873,0.2315695199617256,5TAR,5TAR_FB13A,B,F13A
5TAR_A_B,MB20A,MB18A,INT,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",1.6E-06,1.6e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.906572054036771,-0.215004079649173,5TAR,5TAR_MB18A,B,M18A
5TAR_A_B,WB32A,WB30A,INT,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",7E-06,7e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.032168308549555,0.659399665838043,5TAR,5TAR_WB30A,B,W30A
5TAR_A_B,EB88A,EB86A,COR,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",1.54E-05,1.54e-05,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-6.56504518130134,1.1265227930862585,5TAR,5TAR_EB86A,B,E86A
5TAR_A_B,WB90A,WB88A,COR,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",4.4E-06,4.4e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.307247087151965,0.3843208872356332,5TAR,5TAR_WB88A,B,W88A
5TAR_A_B,QB116A,QB114A,RIM,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",3E-06,3e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.53415160676106,0.1574163676265385,5TAR,5TAR_QB114A,B,Q114A
5TAR_A_B,IB129A,IB127A,INT,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",2.2E-06,2.2e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.717903509303766,-0.0263355349161678,5TAR,5TAR_IB127A,B,I127A
5TAR_A_B,FB133A,FB131A,INT,,"5TAR_A_B,5XCO_A_B,1HE8_A_B",3.5E-06,3.5e-06,2.3E-06,2.3e-06,27791178,K-Ras,PDE delta,298,,,,,,,,,,,,,Chain B is farnesylated right in the binding site,ITC,2,-7.691567974387598,-7.442824730701357,0.2487432436862411,5TAR,5TAR_FB131A,B,F131A
